
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3EAuthor Manuscript%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Calibration of pathogenicity due to variant-induced leaky splicing defects by using BRCA2 exon 3 as a model system - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B3AB69264DA033C3AB60019A29676.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="nihpa">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="manuscript">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7484206/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cancer research">
<meta name="citation_title" content="Calibration of pathogenicity due to variant-induced leaky splicing defects by using BRCA2 exon 3 as a model system">
<meta name="citation_author" content="Hélène Tubeuf">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author_institution" content="Interactive Biosoftware, Rouen, France">
<meta name="citation_author" content="Sandrine M Caputo">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris, France">
<meta name="citation_author_institution" content="PSL Research University, Paris, France">
<meta name="citation_author" content="Teresa Sullivan">
<meta name="citation_author_institution" content="Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.">
<meta name="citation_author" content="Julie Rondeaux">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Sophie Krieger">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author_institution" content="Laboratory of Cancer Biology and Genetics, Centre François Baclesse, Caen, France - Normandie University, UNICAEN, Caen, France">
<meta name="citation_author" content="Virginie Caux-Moncoutier">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris, France">
<meta name="citation_author_institution" content="PSL Research University, Paris, France">
<meta name="citation_author" content="Julie Hauchard">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Gaia Castelain">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Alice Fiévet">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris, France">
<meta name="citation_author_institution" content="INSERM U830, University Paris Descartes, Paris, France">
<meta name="citation_author_institution" content="Service Génétique des Tumeurs, Gustave Roussy, Villejuif, France">
<meta name="citation_author" content="Laëtitia Meulemans">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Françoise Révillion">
<meta name="citation_author_institution" content="Unit of Human Molecular Oncology, Centre Oscar Lambret, Lille, France">
<meta name="citation_author" content="Mélanie Léoné">
<meta name="citation_author_institution" content="Hospices Civils de Lyon, Bron, France">
<meta name="citation_author" content="Nadia Boutry-Kryza">
<meta name="citation_author_institution" content="Hospices Civils de Lyon, Bron, France">
<meta name="citation_author" content="Capucine Delnatte">
<meta name="citation_author_institution" content="Department of Genetics, Nantes University Hospital, Nantes, France">
<meta name="citation_author" content="Marine Guillaud-Bataille">
<meta name="citation_author_institution" content="Service Génétique des Tumeurs, Gustave Roussy, Villejuif, France">
<meta name="citation_author" content="Linda Cleveland">
<meta name="citation_author_institution" content="Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.">
<meta name="citation_author" content="Susan Reid">
<meta name="citation_author_institution" content="Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.">
<meta name="citation_author" content="Eileen Southon">
<meta name="citation_author_institution" content="Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.">
<meta name="citation_author" content="Omar Soukarieh">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Aurélie Drouet">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Daniela Di Giacomo">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Myriam Vezain">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Françoise Bonnet-Dorion">
<meta name="citation_author_institution" content="Inserm U1218, Department of Genetics, Institut Bergonié, Bordeaux, France">
<meta name="citation_author" content="Violaine Bourdon">
<meta name="citation_author_institution" content="Department of Genetics, Institut Paoli-Calmettes, Marseille, France">
<meta name="citation_author" content="Hélène Larbre">
<meta name="citation_author_institution" content="Laboratoire d’Oncogénétique Moléculaire, Institut Godinot, Reims, France">
<meta name="citation_author" content="Danièle Muller">
<meta name="citation_author_institution" content="Unité d’Oncogénétique, Centre Paul Strauss, Strasbourg, France">
<meta name="citation_author" content="Pascal Pujol">
<meta name="citation_author_institution" content="Unité d’Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France">
<meta name="citation_author" content="Fátima Vaz">
<meta name="citation_author_institution" content="Breast Cancer Risk Evaluation Clinic, Portuguese Institute of Oncology of Lisbon, 1099-023 Lisbon, Portugal.">
<meta name="citation_author" content="Séverine Audebert-Bellanger">
<meta name="citation_author_institution" content="Département de Génétique et Biologie de la Reproduction, CHU Morvan, Brest, France">
<meta name="citation_author" content="Chrystelle Colas">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris, France">
<meta name="citation_author_institution" content="PSL Research University, Paris, France">
<meta name="citation_author" content="Laurence Venat-Bouvet">
<meta name="citation_author_institution" content="Service Oncologie, CHU Dupuytren, Limoges, France">
<meta name="citation_author" content="Angela R Solano">
<meta name="citation_author_institution" content="Genotipificacion y Cancer Hereditario, Departmento de Analisis Clinicos, Centro de Educacion Medica e Investigaciones Clinicas (CEMIC), Ciudad Autonoma de Buenos Aires, Argentina">
<meta name="citation_author" content="Dominique Stoppa-Lyonnet">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris, France">
<meta name="citation_author_institution" content="INSERM U830, University Paris Descartes, Paris, France">
<meta name="citation_author" content="Claude Houdayer">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author_institution" content="Department of Genetics, University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Thierry Frebourg">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author_institution" content="Department of Genetics, University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Pascaline Gaildrat">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_author" content="Shyam K Sharan">
<meta name="citation_author_institution" content="Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.">
<meta name="citation_author" content="Alexandra Martins">
<meta name="citation_author_institution" content="Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France">
<meta name="citation_publication_date" content="2020 Jul 8">
<meta name="citation_volume" content="80">
<meta name="citation_issue" content="17">
<meta name="citation_firstpage" content="3593">
<meta name="citation_doi" content="10.1158/0008-5472.CAN-20-0895">
<meta name="citation_pmid" content="32641407">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7484206/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7484206/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7484206/pdf/nihms-1618243.pdf">
<meta name="description" content="BRCA2 is a clinically actionable gene implicated in breast and ovarian cancer predisposition that has become a high priority target for improving the classification of variants of unknown significance (VUS). Amongst all BRCA2 VUS, those causing ...">
<meta name="og:title" content="Calibration of pathogenicity due to variant-induced leaky splicing defects by using BRCA2 exon 3 as a model system">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="BRCA2 is a clinically actionable gene implicated in breast and ovarian cancer predisposition that has become a high priority target for improving the classification of variants of unknown significance (VUS). Amongst all BRCA2 VUS, those causing ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7484206/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="7484206">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1158/0008-5472.CAN-20-0895"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/nihms-1618243.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7484206%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/7484206/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/7484206/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7484206/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-nihpa.png" alt="NIHPA Author Manuscripts logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to NIHPA Author Manuscripts" title="Link to NIHPA Author Manuscripts" shape="default" href="https://www.hhs.gov/open/public-access-guiding-principles/index.html" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cancer Res</button></div>. Author manuscript; available in PMC: 2021 Mar 1.</div>
<div>
<em>Published in final edited form as: </em>Cancer Res. 2020 Jul 8;80(17):3593–3605. doi: <a href="https://doi.org/10.1158/0008-5472.CAN-20-0895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1158/0008-5472.CAN-20-0895</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancer%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancer%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Calibration of pathogenicity due to variant-induced leaky splicing defects by using <em>BRCA2</em> exon 3 as a model system</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tubeuf%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Hélène Tubeuf</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Hélène Tubeuf</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">
<sup>2</sup>Interactive Biosoftware, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tubeuf%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hélène Tubeuf</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caputo%20SM%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Sandrine M Caputo</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Sandrine M Caputo</span></h3>
<div class="p">
<sup>3</sup>Department of Genetics, Institut Curie, Paris, France</div>
<div class="p">
<sup>4</sup>PSL Research University, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caputo%20SM%22%5BAuthor%5D" class="usa-link"><span class="name western">Sandrine M Caputo</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sullivan%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Teresa Sullivan</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Teresa Sullivan</span></h3>
<div class="p">
<sup>5</sup>Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sullivan%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Teresa Sullivan</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rondeaux%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Julie Rondeaux</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Julie Rondeaux</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rondeaux%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julie Rondeaux</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Krieger%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Sophie Krieger</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Sophie Krieger</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">
<sup>6</sup>Laboratory of Cancer Biology and Genetics, Centre François Baclesse, Caen, France - Normandie University, UNICAEN, Caen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Krieger%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sophie Krieger</span></a>
</div>
</div>
<sup>1,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caux-Moncoutier%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Virginie Caux-Moncoutier</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Virginie Caux-Moncoutier</span></h3>
<div class="p">
<sup>3</sup>Department of Genetics, Institut Curie, Paris, France</div>
<div class="p">
<sup>4</sup>PSL Research University, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caux-Moncoutier%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Virginie Caux-Moncoutier</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hauchard%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Julie Hauchard</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Julie Hauchard</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hauchard%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julie Hauchard</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Castelain%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Gaia Castelain</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Gaia Castelain</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Castelain%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gaia Castelain</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fi%C3%A9vet%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Alice Fiévet</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Alice Fiévet</span></h3>
<div class="p">
<sup>3</sup>Department of Genetics, Institut Curie, Paris, France</div>
<div class="p">
<sup>7</sup>INSERM U830, University Paris Descartes, Paris, France</div>
<div class="p">
<sup>8</sup>Service Génétique des Tumeurs, Gustave Roussy, Villejuif, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fi%C3%A9vet%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alice Fiévet</span></a>
</div>
</div>
<sup>3,</sup><sup>7,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meulemans%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Laëtitia Meulemans</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Laëtitia Meulemans</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meulemans%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laëtitia Meulemans</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22R%C3%A9villion%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Françoise Révillion</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Françoise Révillion</span></h3>
<div class="p">
<sup>9</sup>Unit of Human Molecular Oncology, Centre Oscar Lambret, Lille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22R%C3%A9villion%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Françoise Révillion</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22L%C3%A9on%C3%A9%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Mélanie Léoné</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Mélanie Léoné</span></h3>
<div class="p">
<sup>10</sup>Hospices Civils de Lyon, Bron, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22L%C3%A9on%C3%A9%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mélanie Léoné</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boutry-Kryza%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Nadia Boutry-Kryza</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Nadia Boutry-Kryza</span></h3>
<div class="p">
<sup>10</sup>Hospices Civils de Lyon, Bron, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boutry-Kryza%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nadia Boutry-Kryza</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delnatte%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Capucine Delnatte</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Capucine Delnatte</span></h3>
<div class="p">
<sup>11</sup>Department of Genetics, Nantes University Hospital, Nantes, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delnatte%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Capucine Delnatte</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guillaud-Bataille%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Marine Guillaud-Bataille</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Marine Guillaud-Bataille</span></h3>
<div class="p">
<sup>8</sup>Service Génétique des Tumeurs, Gustave Roussy, Villejuif, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guillaud-Bataille%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marine Guillaud-Bataille</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cleveland%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Linda Cleveland</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Linda Cleveland</span></h3>
<div class="p">
<sup>5</sup>Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cleveland%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Linda Cleveland</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reid%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Susan Reid</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Susan Reid</span></h3>
<div class="p">
<sup>5</sup>Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reid%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Susan Reid</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Southon%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Eileen Southon</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Eileen Southon</span></h3>
<div class="p">
<sup>5</sup>Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Southon%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eileen Southon</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soukarieh%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Omar Soukarieh</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Omar Soukarieh</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soukarieh%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Omar Soukarieh</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Drouet%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Aurélie Drouet</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Aurélie Drouet</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Drouet%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aurélie Drouet</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giacomo%20DD%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Daniela Di Giacomo</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Daniela Di Giacomo</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giacomo%20DD%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniela Di Giacomo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vezain%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Myriam Vezain</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Myriam Vezain</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vezain%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Myriam Vezain</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonnet-Dorion%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Françoise Bonnet-Dorion</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Françoise Bonnet-Dorion</span></h3>
<div class="p">
<sup>12</sup>Inserm U1218, Department of Genetics, Institut Bergonié, Bordeaux, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonnet-Dorion%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Françoise Bonnet-Dorion</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bourdon%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Violaine Bourdon</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Violaine Bourdon</span></h3>
<div class="p">
<sup>13</sup>Department of Genetics, Institut Paoli-Calmettes, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bourdon%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Violaine Bourdon</span></a>
</div>
</div>
<sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Larbre%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Hélène Larbre</span></a><div hidden="hidden" id="id25">
<h3><span class="name western">Hélène Larbre</span></h3>
<div class="p">
<sup>14</sup>Laboratoire d’Oncogénétique Moléculaire, Institut Godinot, Reims, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Larbre%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hélène Larbre</span></a>
</div>
</div>
<sup>14</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Muller%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id26"><span class="name western">Danièle Muller</span></a><div hidden="hidden" id="id26">
<h3><span class="name western">Danièle Muller</span></h3>
<div class="p">
<sup>15</sup>Unité d’Oncogénétique, Centre Paul Strauss, Strasbourg, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Muller%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Danièle Muller</span></a>
</div>
</div>
<sup>15</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pujol%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id27"><span class="name western">Pascal Pujol</span></a><div hidden="hidden" id="id27">
<h3><span class="name western">Pascal Pujol</span></h3>
<div class="p">
<sup>16</sup>Unité d’Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pujol%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pascal Pujol</span></a>
</div>
</div>
<sup>16</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vaz%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id28"><span class="name western">Fátima Vaz</span></a><div hidden="hidden" id="id28">
<h3><span class="name western">Fátima Vaz</span></h3>
<div class="p">
<sup>17</sup>Breast Cancer Risk Evaluation Clinic, Portuguese Institute of Oncology of Lisbon, 1099-023 Lisbon, Portugal.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vaz%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fátima Vaz</span></a>
</div>
</div>
<sup>17</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Audebert-Bellanger%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id29"><span class="name western">Séverine Audebert-Bellanger</span></a><div hidden="hidden" id="id29">
<h3><span class="name western">Séverine Audebert-Bellanger</span></h3>
<div class="p">
<sup>18</sup>Département de Génétique et Biologie de la Reproduction, CHU Morvan, Brest, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Audebert-Bellanger%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Séverine Audebert-Bellanger</span></a>
</div>
</div>
<sup>18</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Colas%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id30"><span class="name western">Chrystelle Colas</span></a><div hidden="hidden" id="id30">
<h3><span class="name western">Chrystelle Colas</span></h3>
<div class="p">
<sup>3</sup>Department of Genetics, Institut Curie, Paris, France</div>
<div class="p">
<sup>4</sup>PSL Research University, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Colas%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chrystelle Colas</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Venat-Bouvet%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id31"><span class="name western">Laurence Venat-Bouvet</span></a><div hidden="hidden" id="id31">
<h3><span class="name western">Laurence Venat-Bouvet</span></h3>
<div class="p">
<sup>19</sup>Service Oncologie, CHU Dupuytren, Limoges, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Venat-Bouvet%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laurence Venat-Bouvet</span></a>
</div>
</div>
<sup>19</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Solano%20AR%22%5BAuthor%5D" class="usa-link" aria-describedby="id32"><span class="name western">Angela R Solano</span></a><div hidden="hidden" id="id32">
<h3><span class="name western">Angela R Solano</span></h3>
<div class="p">
<sup>20</sup>Genotipificacion y Cancer Hereditario, Departmento de Analisis Clinicos, Centro de Educacion Medica e Investigaciones Clinicas (CEMIC), Ciudad Autonoma de Buenos Aires, Argentina</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Solano%20AR%22%5BAuthor%5D" class="usa-link"><span class="name western">Angela R Solano</span></a>
</div>
</div>
<sup>20</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stoppa-Lyonnet%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id33"><span class="name western">Dominique Stoppa-Lyonnet</span></a><div hidden="hidden" id="id33">
<h3><span class="name western">Dominique Stoppa-Lyonnet</span></h3>
<div class="p">
<sup>3</sup>Department of Genetics, Institut Curie, Paris, France</div>
<div class="p">
<sup>7</sup>INSERM U830, University Paris Descartes, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stoppa-Lyonnet%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dominique Stoppa-Lyonnet</span></a>
</div>
</div>
<sup>3,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Houdayer%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id34"><span class="name western">Claude Houdayer</span></a><div hidden="hidden" id="id34">
<h3><span class="name western">Claude Houdayer</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">
<sup>21</sup>Department of Genetics, University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Houdayer%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claude Houdayer</span></a>
</div>
</div>
<sup>1,</sup><sup>21</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frebourg%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id35"><span class="name western">Thierry Frebourg</span></a><div hidden="hidden" id="id35">
<h3><span class="name western">Thierry Frebourg</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">
<sup>21</sup>Department of Genetics, University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frebourg%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thierry Frebourg</span></a>
</div>
</div>
<sup>1,</sup><sup>21</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gaildrat%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id36"><span class="name western">Pascaline Gaildrat</span></a><div hidden="hidden" id="id36">
<h3><span class="name western">Pascaline Gaildrat</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gaildrat%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pascaline Gaildrat</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sharan%20SK%22%5BAuthor%5D" class="usa-link" aria-describedby="id37"><span class="name western">Shyam K Sharan</span></a><div hidden="hidden" id="id37">
<h3><span class="name western">Shyam K Sharan</span></h3>
<div class="p">
<sup>5</sup>Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sharan%20SK%22%5BAuthor%5D" class="usa-link"><span class="name western">Shyam K Sharan</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martins%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id38"><span class="name western">Alexandra Martins</span></a><div hidden="hidden" id="id38">
<h3><span class="name western">Alexandra Martins</span></h3>
<div class="p">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martins%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexandra Martins</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="A1">
<sup>1</sup>Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div id="A2">
<sup>2</sup>Interactive Biosoftware, Rouen, France</div>
<div id="A3">
<sup>3</sup>Department of Genetics, Institut Curie, Paris, France</div>
<div id="A4">
<sup>4</sup>PSL Research University, Paris, France</div>
<div id="A5">
<sup>5</sup>Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.</div>
<div id="A6">
<sup>6</sup>Laboratory of Cancer Biology and Genetics, Centre François Baclesse, Caen, France - Normandie University, UNICAEN, Caen, France</div>
<div id="A7">
<sup>7</sup>INSERM U830, University Paris Descartes, Paris, France</div>
<div id="A8">
<sup>8</sup>Service Génétique des Tumeurs, Gustave Roussy, Villejuif, France</div>
<div id="A9">
<sup>9</sup>Unit of Human Molecular Oncology, Centre Oscar Lambret, Lille, France</div>
<div id="A10">
<sup>10</sup>Hospices Civils de Lyon, Bron, France</div>
<div id="A11">
<sup>11</sup>Department of Genetics, Nantes University Hospital, Nantes, France</div>
<div id="A12">
<sup>12</sup>Inserm U1218, Department of Genetics, Institut Bergonié, Bordeaux, France</div>
<div id="A13">
<sup>13</sup>Department of Genetics, Institut Paoli-Calmettes, Marseille, France</div>
<div id="A14">
<sup>14</sup>Laboratoire d’Oncogénétique Moléculaire, Institut Godinot, Reims, France</div>
<div id="A15">
<sup>15</sup>Unité d’Oncogénétique, Centre Paul Strauss, Strasbourg, France</div>
<div id="A16">
<sup>16</sup>Unité d’Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France</div>
<div id="A17">
<sup>17</sup>Breast Cancer Risk Evaluation Clinic, Portuguese Institute of Oncology of Lisbon, 1099-023 Lisbon, Portugal.</div>
<div id="A18">
<sup>18</sup>Département de Génétique et Biologie de la Reproduction, CHU Morvan, Brest, France</div>
<div id="A19">
<sup>19</sup>Service Oncologie, CHU Dupuytren, Limoges, France</div>
<div id="A20">
<sup>20</sup>Genotipificacion y Cancer Hereditario, Departmento de Analisis Clinicos, Centro de Educacion Medica e Investigaciones Clinicas (CEMIC), Ciudad Autonoma de Buenos Aires, Argentina</div>
<div id="A21">
<sup>21</sup>Department of Genetics, University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France</div>
<div class="author-notes p"><div class="fn" id="CR1">
<sup>*</sup><p class="display-inline">Corresponding author: Alexandra Martins; address: Inserm U1245, UFR de Médecine et Pharmacie, 22 Bvd Gambetta, CS 76183, 76183 Rouen Cedex 1, France; phone: + 33 (0)2 35 14 83 14; <span>alexandra.martins@univ-rouen.fr</span>.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Issue date 2020 Sep 1.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div>PMCID: PMC7484206  NIHMSID: NIHMS1618243  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32641407/" class="usa-link">32641407</a>
</div>
<div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>The publisher's version of this article is available at <a href="https://doi.org/10.1158/0008-5472.CAN-20-0895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Cancer Res</a>
</div></div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="ABS1"><h2>Abstract</h2>
<p id="P1"><em>BRCA2</em> is a clinically actionable gene implicated in breast and ovarian cancer predisposition that has become a high priority target for improving the classification of variants of unknown significance (VUS). Amongst all <em>BRCA2</em> VUS, those causing partial/leaky splicing defects are the most challenging to classify because the minimal level of full-length transcripts (FL) required for normal function remains to be established. Here, we explored <em>BRCA2</em> exon 3 (<em>BRCA2</em>e3) as a model for calibrating variant-induced spliceogenicity and estimating thresholds for <em>BRCA2</em> haploinsufficiency. <em>In silico</em> predictions, minigene splicing assays, patients’ RNA analyses, a mouse embryonic stem cell (mESC) complementation assay and retrieval of patient-related information were combined to determine the minimal requirement of FL <em>BRCA2</em> transcripts. Of 100 <em>BRCA2</em>e3 variants tested in the minigene assay, 64 were found to be spliceogenic causing mild to severe RNA defects. Splicing defects were also confirmed in patients’ RNA when available. Analysis of a neutral leaky variant (c.231T&gt;G) showed that a reduction to ~60% of FL <em>BRCA2</em> transcripts from a mutant allele does not cause any increase in cancer risk. Moreover, data obtained from mESCs suggest that variants causing a decline in FL <em>BRCA2</em> to ~30% of wild-type are not pathogenic given that mESCs are fully viable and resistant to DNA-damaging agents in those conditions. In contrast, mESCs producing lower relative amounts of FL <em>BRCA2</em> exhibited either null or hypomorphic phenotypes. Overall, our findings are likely to have broader implications on the interpretation of <em>BRCA2</em> variants affecting the splicing pattern of other essential exons.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> <em>BRCA2</em> exon 3, haploinsufficiency thresholds, variants of unknown significance (VUS), RNA splicing, functional assays</p></section></section><section id="S1"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p id="P2">Since the identification of <em>BRCA1</em> (MIM #113705) and <em>BRCA2</em> (MIM #600185) as major hereditary breast and ovarian cancer (HBOC) genes, mutation screening has led to the discovery of 20,000 unique germline <em>BRCA1</em> and <em>BRCA2</em> variants (<a href="#R1" class="usa-link" aria-describedby="R1">1</a>). In female carriers of pathogenic <em>BRCA1</em> and <em>BRCA2</em> variants, the cumulative risk by 80 years of age of developing breast cancer was estimated at 72% and 69% and that of developing ovarian cancer at 44% and 17%, respectively (<a href="#R2" class="usa-link" aria-describedby="R2">2</a>). Heterozygous <em>BRCA2</em> mutations also confer moderate risk to pancreatic and prostate cancers (<a href="#R3" class="usa-link" aria-describedby="R3">3</a>). Moreover, bi-allelic <em>BRCA2</em> mutations are causative of Fanconi anemia (FA) where one allele is often hypomorphic (<a href="#R4" class="usa-link" aria-describedby="R4">4</a>). Today, one of the most important bottlenecks in HBOC diagnosis is the high fraction of variants of unknown significance (VUS) detected in the <em>BRCA</em> genes, estimated at ~50% of the detected variants (<a href="#R5" class="usa-link" aria-describedby="R5">5</a>–<a href="#R9" class="usa-link" aria-describedby="R9">9</a>). Carriers of VUS and their relatives cannot benefit from cancer-risk-reducing strategies, such as increased surveillance and prophylactic surgery, or from targeted therapies. VUS are generally typified by missense changes, but also include synonymous substitutions, small in-frame insertions and deletions as well as intronic variants, all of which can potentially affect pre-mRNA splicing (<a href="#R10" class="usa-link" aria-describedby="R10">10</a>). A significant number of <em>BRCA</em> VUS has been shown to induce RNA splicing defects (<a href="#R11" class="usa-link" aria-describedby="R11">11</a>). Splicing defects that lead to the exclusive production of aberrant transcripts carrying a premature termination codon (PTC) or of in-frame deletions disrupting known functional domain(s) (<a href="#R12" class="usa-link" aria-describedby="R12">12</a>) are regarded as pathogenic. In contrast, the biological consequences of variants that lead to partial/leaky splicing defects (<em>i.e.</em> that still produce a certain level of full-length reference transcripts) remain unknown. In this respect, variants affecting the in-frame alternatively spliced <em>BRCA2</em> exon 3 (<em>BRCA2</em>e3) are particularly challenging to interpret.</p>
<p id="P3"><em>BRCA2</em>e3 encodes an essential bipartite region comprised of (i) a transactivation core that interacts with EMSY, and (ii) a PALB2-interaction domain that allows the recruitment of BRCA2 to the site of double stand breaks (DSBs) to mediate homologous recombination (HR) (<a href="#SD1" class="usa-link">Supplementary Figure S1A</a>) (<a href="#R13" class="usa-link" aria-describedby="R13">13</a>,<a href="#R14" class="usa-link" aria-describedby="R14">14</a>). Recently, it was demonstrated that variants that trigger total skipping of BRCA2e3 (leading to a 249-nucleotide in-frame deletion, Δ3; <a href="#SD1" class="usa-link">Supplementary Figure S1B</a>), such as c.316+5G&gt;C, confer high-risk of developing <em>BRCA2</em>-associated cancers (<a href="#R12" class="usa-link" aria-describedby="R12">12</a>). In contrast, the biological impact of variants causing partial <em>BRCA2</em>e3 skipping remains unknown and their contribution to <em>BRCA2</em> haploinsufficiency and pathogenicity is not yet established. Indeed, the minimal level of full-length transcripts that can provide sufficient <em>BRCA2</em> function is still unknown. A low proportion of naturally occurring alternatively spliced transcripts lacking <em>BRCA2</em>e3 (Δ3~1–3%) has been detected in normal tissues, including blood, mammary glands and prostate tissues (<a href="#R15" class="usa-link" aria-describedby="R15">15</a>–<a href="#R18" class="usa-link" aria-describedby="R18">18</a>). Furthermore, despite causing increased levels of Δ3 transcripts (estimated at ~20% in blood-derived samples), c.68–7T&gt;A was recently found to be a non-pathogenic variant as it was not associated with increased risk of breast cancer (posterior probability of 7.44×10<sup>−115</sup>) (<a href="#R19" class="usa-link" aria-describedby="R19">19</a>). Here, we hypothesized that <em>BRCA2</em>e3 variants with partial effects on splicing, though stronger than c.68–7T&gt;A, would confer minimal to severe reduction in <em>BRCA2</em> function, depending on the severity of exon 3 skipping. These variants could thus be associated with varying degrees of cancer susceptibility.</p>
<p id="P4">We therefore investigated the impact of 100 variants on <em>BRCA2</em>e3 splicing by utilizing both <em>in silico</em> tools and functional assays. The biological consequences of seven non-coding variants (intronic or synonymous) that cause gradual increase of <em>BRCA2</em>e3 skipping were then assessed in a mouse embryonic stem cell (mESC)-based complementation assay. In addition, we collected patient-related data for these variants. We conclude that <em>BRCA2</em> tumor suppressor activity may tolerate substantial reduction in the level of full-length transcripts, a finding that could contribute to improve <em>BRCA</em> variant classification guidelines.</p></section><section id="S2"><h2 class="pmc_sec_title">MATERIALS AND METHODS</h2>
<section id="S3"><h3 class="pmc_sec_title">Variant selection</h3>
<p id="P5">To calibrate the potential spliceogenicity of <em>BRCA2</em>e3 variants, we started by focusing on 74 translationally silent/non-coding variants (intronic or synonymous) most of which were bioinformatically predicted to induce <em>BRCA2</em>e3 splicing defects (<a href="#SD1" class="usa-link">Supplementary Figure S2</a> and <a href="#SD2" class="usa-link">Supplementary Table S1</a>). These included 61 non-coding variants that were expected to affect <em>BRCA2</em>e3 splicing by either weakening the strength of 3’ and 5’ splice sites (3’ss and 5’ss) (n=21, <a href="#SD1" class="usa-link">Supplementary Figure S3A</a>–<a href="#SD1" class="usa-link">B</a>) or by disrupting putative splicing regulatory elements (SREs) (n=40, <a href="#SD1" class="usa-link">Supplementary Figure S4</a>). Bioinformatics predictions of variant-induced alterations of 3’ss and 5’ss strength were performed with MaxEntScan (MES) and SpliceSiteFinder-like (SSFL), interrogated by using either Alamut Batch v1.9 or Alamut Visual v2.11 integrated software tools (Interactive Biosoftware, <a href="http://www.interactive-biosoftware.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.interactive-biosoftware.com</a>), as well as SPiCE (RRID: SCR_016603, <a href="https://sourceforge.net/projects/spicev2-1/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://sourceforge.net/projects/spicev2-1/</a>) (<a href="#R20" class="usa-link" aria-describedby="R20">20</a>). Predictions of variant-induced SRE alterations were obtained with four SRE-predictors, namely: QUEPASA (<a href="#R21" class="usa-link" aria-describedby="R21">21</a>,<a href="#R22" class="usa-link" aria-describedby="R22">22</a>) and HEXplorer (<a href="#R23" class="usa-link" aria-describedby="R23">23</a>), for which the ΔtESRseq and ΔHZ<sub>EI</sub> scores, respectively, were calculated with the Alamut Batch prototype tool version 1.5.2 (ESRseq), (<a href="http://www.interactive-biosoftware.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.interactive-biosoftware.com</a>) as well as SPANR (<a href="#R24" class="usa-link" aria-describedby="R24">24</a>) and HAL (<a href="#R25" class="usa-link" aria-describedby="R25">25</a>), for which ΔΨ scores were retrieved from the corresponding online interfaces (<a href="http://tools.genes.toronto.edu/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://tools.genes.toronto.edu</a> and <a href="http://splicing.cs.washington.edu/SE" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://splicing.cs.washington.edu/SE</a>, respectively). Variants were selected based on the “at least three” rule, i.e; we considered that the most probable spliceogenic variants were those predicted as such by at least three SRE-predictors according to thresholds described in (<a href="#R26" class="usa-link" aria-describedby="R26">26</a>), and shown in <a href="#SD1" class="usa-link">Supplementary Figure S4</a>. In addition and without prior knowledge of splicing predictions, we also integrated 13 non-coding <em>BRCA2</em> variants classified as VUS (or with discordant classifications in different databases) which had been detected in probands undergoing genetic testing in diagnostic laboratories from the French GGC-Unicancer network (<a href="#SD1" class="usa-link">Supplementary Figure S2</a>, <a href="#SD2" class="usa-link">Supplementary Table S1</a> and <a href="#SD1" class="usa-link">Supplementary Note</a>).</p>
<p id="P6">After the initial calibration experiments with the 74 non-coding variants, we also performed functional analyses with a set of missense variants (n=24) identified in probands undergoing genetic counselling. Two pathogenic variants, c.92G&gt;A (p.Trp31*) and c.145G&gt;T (p.Glu49*), which were previously described as spliceogenic in minigene splicing assays (<a href="#R27" class="usa-link" aria-describedby="R27">27</a>,<a href="#R28" class="usa-link" aria-describedby="R28">28</a>), were also retained as controls. Therefore, altogether, our collection included a total of 100 <em>BRCA2e3</em> variants.</p></section><section id="S4"><h3 class="pmc_sec_title">Minigene splicing assays</h3>
<p id="P7">In order to evaluate the impact on splicing of the 100 <em>BRCA2</em>e3 variants, we performed functional assays based on the comparative analysis of the splicing pattern of wild-type (WT) and mutant reporter minigenes. Minigenes were prepared by using the pCAS2 vector backbone as previously described (<a href="#R26" class="usa-link" aria-describedby="R26">26</a>,<a href="#R29" class="usa-link" aria-describedby="R29">29</a>) and explained in <a href="#SD1" class="usa-link">Supplementary Material and Methods</a>.</p></section><section id="S5"><h3 class="pmc_sec_title">Analysis of the <em>BRCA2</em> exon 3 splicing pattern in RNA samples from patients and control individuals</h3>
<p id="P8">RNA samples from EBV-immortalized lymphoblastoid cell lines (LCLs) or PAXgene-stabilized blood of healthy donors and patients were collected in collaboration with the GGC-Unicancer consortium (<a href="#SD1" class="usa-link">Supplemental Note</a>). The splicing patterns of <em>BRCA2</em> transcripts expressed in LCL or PAXgene samples were analyzed by semi-quantitative fluorescent RT-PCR (26 and 40 cycles, respectively), as further described in <a href="#SD1" class="usa-link">Supplementary Material and Methods</a>, with primers mapping to <em>BRCA2</em> exons 2 and 5 (<a href="#SD2" class="usa-link">Supplementary Table S2</a>).</p></section><section id="S6"><h3 class="pmc_sec_title">Allele-specific expression analysis</h3>
<p id="P9">Allele-specific expression (ASE) of <em>BRCA2</em>e3-containing transcripts (FL) was measured by performing a quantitative primer extension assay (SNaPshot MultiplexKit, Applied Biosystem), as previously described (<a href="#R29" class="usa-link" aria-describedby="R29">29</a>), using specific primers targeting the variants of interest (<a href="#SD2" class="usa-link">Supplementary Table S2</a>) and semi-quantitative RT-PCR conditions further detailed in <a href="#SD1" class="usa-link">Supplementary Material and Methods</a>.</p></section><section id="S7"><h3 class="pmc_sec_title">Mouse embryonic stem cells-based complementation assay</h3>
<p id="P10">To assess the functional impact of <em>BRCA2</em>e3 variants, we took advantage of a mouse embryonic stem cell-based assay (<a href="#R30" class="usa-link" aria-describedby="R30">30</a>,<a href="#R31" class="usa-link" aria-describedby="R31">31</a>). Mouse ESC expressing the human <em>BRCA2</em> gene (<em>hBRCA2</em>) carrying specific variants were generated as previously described (<a href="#R30" class="usa-link" aria-describedby="R30">30</a>,<a href="#R31" class="usa-link" aria-describedby="R31">31</a>) with a few modifications as detailed in <a href="#SD1" class="usa-link">Supplementary Material and Methods</a>. After Cre-mediated deletion of the conditional mouse <em>Brca</em>2 allele (<em>mBrca2</em>), we assessed cell survival and sensitivity to DNA-damaging agents, as previously described (<a href="#R30" class="usa-link" aria-describedby="R30">30</a>,<a href="#R31" class="usa-link" aria-describedby="R31">31</a>). The splicing patterns of <em>BRCA2</em>e3 were analysed by semi-quantitative fluorescent RT-PCR (24 cycles), as described for patient RNA.</p></section><section id="S8"><h3 class="pmc_sec_title">Patient and family data</h3>
<p id="P11">Genetic, clinical, familial, and tumoral data for patients carrying <em>BRCA2</em>e3 variants were collected in collaboration with the French GGC network and within the framework of the COsegregation of VARiants in the <em>BRCA1/2</em> and <em>PALB2</em> genes clinical trial (COVAR, <a href="#SD1" class="usa-link">Supplementary Note</a>). The criteria for diagnostic variant screening of the <em>BRCA2</em> gene were applied according to the current French GGC recommendations and the French National Cancer Institute (INCa) guidelines. Informed written consent was obtained from all patients.</p></section></section><section id="S9"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="S10"><h3 class="pmc_sec_title">Identification of variants affecting <em>BRCA2</em>e3 splicing by using a minigene splicing assay</h3>
<p id="P12">To get a glimpse of <em>BRCA2e3</em> vulnerability to predicted splicing mutations and to calibrate the spliceogenicity of this exon, we started by evaluating the impact on splicing of 74 non-coding variants by performing a minigene assay (<a href="#F1" class="usa-link">Figure 1A</a>). These variants, which map either to exon 3 or its flanking intronic regions, included 61 non-coding variants bioinformatically predicted to induce exon skipping (19 intronic, 2 synonymous but overlapping exon-intron junctions and 40 exonic synonymous variants; 26/61 being naturally occurring variants described in Human variation databases). We included 13 additional non-coding variants that were selected because they were either classified as VUS in BRCA-Share or had conflicting interpretations in other databases (4 intronic and 9 exonic synonymous) (<a href="#SD1" class="usa-link">Supplementary Figures S2</a>–<a href="#SD1" class="usa-link">S4</a>, and <a href="#SD2" class="usa-link">Supplementary Table S1</a>).</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1. Identification of <em>BRCA2</em> exon 3 spliceogenic variants among translationally silent genetic alterations by using a minigene splicing assay.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb5/7484206/1b40952677a1/nihms-1618243-f0001.jpg" loading="lazy" height="1621" width="1920" alt="Figure 1."></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P41"><strong>(A) Distribution of the 74 variants reported within or in the vincity of <em>BRCA2</em> exon 3.</strong> The diagram shows the relative position and identity of each variant within <em>BRCA2</em>e3 and flanking intronic regions. <strong>(B) Impact on splicing of non-coding <em>BRCA2</em> exon 3 variants.</strong> Wild-type (WT) and mutant pCAS2-<em>BRCA2</em>-e3 minigene constructs were transiently expressed in HeLa cells. The splicing patterns of the RNA produced from the different minigenes were then analyzed by semi-quantitative fluorescent RT-PCR followed by capillary electrophoresis. Results represent the mean of relative exon 3 inclusion (% FL) of three independent transfection experiments. Error bars indicate standard error of mean values. <strong>(C) Splicing pattern of pCAS2-<em>BRCA2</em>e3 minigenes carrying selected variants that cause gradual increase in <em>BRCA2</em>e3 skipping</strong>. The top panel shows the RT-PCR products separated on an agarose gel, whereas the bottom panel indicates the relative quantification of the fluorescent RT-PCR products separated by capillary electrophoresis. Results represent the mean of three independent transfection experiments. Error bars indicate standard error of mean values. The identities of the two RT-PCR products obtained, with (FL) or without (Δ3) exon 3, are indicated on the right. FL+Δ3 correspond to heteroduplexes containing the two products. E3, exon 3.</p></figcaption></figure><p id="P13">The minigene splicing assay, which was based on pCAS2-BRCA2e3-derived constructs (<a href="#SD1" class="usa-link">Supplementary Figure S5</a>), revealed that 52 out of the 74 variants (70%) altered the splicing pattern of <em>BRCA2</em>e3 whereas the 22/74 remaining variants (30%) showed no major effect on splicing (<a href="#F1" class="usa-link">Figure 1B</a> and <a href="#SD2" class="usa-link">Supplementary Table S1</a>). More precisely, 51 variants induced <em>BRCA2</em>e3 skipping to different extents (6%−100% Δ3, <em>i.e.</em> 94%−0% FL) and 1 variant (c.68–1G&gt;A) resulted in complete deletion of six nucleotides at the beginning of the exon, due to the creation of a new 3’ss (<a href="#SD1" class="usa-link">Supplementary Figure S6</a>). Because it causes a small in-frame deletion, the latter should now be considered a VUS instead of a likely pathogenic variant as currently indicated in ClinVar. We found that <em>in silico</em> analyses were generally useful for predicting variant-induced splicing alterations but that not all predictions were correct (<a href="#SD2" class="usa-link">Supplementary Tables S1</a>, <a href="#SD2" class="usa-link">S3</a>–<a href="#SD2" class="usa-link">S5</a>, <a href="#SD1" class="usa-link">Supplementary Figures S7A</a>–<a href="#SD1" class="usa-link">B</a>, <a href="#SD1" class="usa-link">S8A</a>–<a href="#SD1" class="usa-link">E</a> and <a href="#SD1" class="usa-link">S9A</a>–<a href="#SD1" class="usa-link">E</a>). For instance, the naturally occurring c.231T&gt;G synonymous VUS caused 31% Δ3 (69% FL), which is concordant with a previous experimental study (<a href="#R32" class="usa-link" aria-describedby="R32">32</a>) but disagrees with the SRE predictions (<a href="#SD2" class="usa-link">Supplementary Table S1</a>). In sum, these data suggest that the regulation of <em>BRCA2e3</em> splicing is very plastic and allowed us to initiate a calibration of the variant-induced spliceogenicity of this exon. Indeed, we observed a spectrum of splicing alterations varying from mild (corresponding to a level of exon inclusion lower than WT, <em>i.e.</em> &lt;99%, but ≥92 %, a threshold defined by the effect of the neutral c.68–7T&gt;A variant) to drastic (exon inclusion ≤5 %, defined by the impact of the pathogenic c.316+5G&gt;C variant) (<a href="#F1" class="usa-link">Figure 1B</a>). Based on this comparative analysis, we infer that the non-coding variants in our dataset that show levels of exon inclusion in the minigene assay equal or superior to c.68–7T&gt;A are neutral, whereas those that lead to exon inclusion levels equal or inferior to c.316+5G&gt;C are pathogenic. Seven VUS causing intermediate levels of exon inclusion (92%&gt;FL&gt;5%) were retained for further analysis because they illustrate the continuum of variant-induced FL transcript loss observed in the minigene assay and could eventually help in defining a Δ3 threshold for pathogenicity (c.165C&gt;T, c.231T&gt;G, c.68–8_68–7delinsAA, c.102A&gt;G, c.316+6T&gt;C, c.316+6T&gt;A and c.316+6T&gt;G, in increasing order of severity; <a href="#F1" class="usa-link">Figure 1C</a>).</p></section><section id="S11"><h3 class="pmc_sec_title">Confirmation of variant-induced spliceogenicity in RNA samples from HBOC patients</h3>
<p id="P14">To assess the physiological relevance of the splicing defects revealed by the minigene assay, we analyzed the splicing pattern of <em>BRCA2</em>e3 in human-derived samples, either LCL or PAXgene-stabilized blood, obtained from control individuals and from four patients carrying <em>BRCA2</em>e3 variants (c.231T&gt;G, c.68–8_68–7delinsAA, c.102A&gt;G and c.316+6T&gt;C). No biological samples were available for carriers of c.165C&gt;T, c.316+6T&gt;A and c.316+6T&gt;G. Besides LCL and PAXgene samples from healthy individuals, two additional controls were used in this experiment: (i) a LCL from a patient harboring an unequivocal pathogenic Alu insertion in the middle of exon 3 (c.156_157insAlu) known to cause total exon skipping (<a href="#R33" class="usa-link" aria-describedby="R33">33</a>) and LCLs from four carriers of the neutral variant c.68–7T&gt;A, known to lead to mild exon skipping (<a href="#R19" class="usa-link" aria-describedby="R19">19</a>). The bi-allelic splicing patterns of <em>BRCA2</em>e3 in patient biological samples were analyzed by semi-quantitative RT-PCR, a common approach used in clinical settings (<a href="#R34" class="usa-link" aria-describedby="R34">34</a>), and compared to those generated from equivalent RNA samples of control individuals (<a href="#F2" class="usa-link">Figure 2A</a>–<a href="#F2" class="usa-link">B</a>, <a href="#SD2" class="usa-link">Supplementary Table S1</a>). In LCL and PAXgene samples from healthy controls, we detected the natural alternative splicing pattern of <em>BRCA2e3</em> with ~10% Δ3, whereas carriers of c.68–7T&gt;A displayed ~25% Δ3. These splicing patterns are comparable to previous reports of ~3% Δ3 in LCL control samples and ~13% Δ3 in carriers of c.68–7T&gt;A as determined by RT-qPCR (<a href="#R19" class="usa-link" aria-describedby="R19">19</a>). Importantly, heterozygous carriers of c.231T&gt;G, c.68–8_68–7delinsAA, c.102A&gt;G and c.316+6T&gt;C showed a decrease in the relative amount of FL transcripts due to an increase in Δ3 (75%−38% FL; <em>i.e</em>. 25%−62% Δ3). These relative levels of Δ3 were lower than that observed for c.156_157insAlu (FL=30%, <em>i.e</em>. Δ3=70%), suggesting that these four variants are leaky not only in the minigene assay but also in patients’ cells. Nevertheless, assuming a balanced bi-allelic expression of <em>BRCA2</em> and taking into account that WT alleles seem to contribute to ~10% Δ3, it was expected that the LCL carrying the heterozygous c.156_157insAlu variant would display ~55% Δ3, instead of 70% as detected. It is thus possible that our RT-PCR conditions slightly overestimate the level of Δ3 possibly due to a PCR bias favoring the amplification of the smaller Δ3 RT-PCR products relative to FL. A similar impact on exon 3 splicing was observed by Colombo and co-workers but the effect was more exacerbated probably due to a higher number of PCR amplification cycles (<a href="#R19" class="usa-link" aria-describedby="R19">19</a>). Sequencing of the FL RT-PCR products of patients carrying the heterozygous c.231T&gt;G variant showed the presence of both WT and mutant FL transcripts, with mutant FL transcripts appearing to be under-represented as compared to WT, further suggesting that this variation cause partial splicing defects (<a href="#SD1" class="usa-link">Supplementary Figure S10</a>). These results obtained from patient-derived RNA samples are in agreement with the minigene data. Indeed, we observed a good correlation (R<sup>2</sup>=0.9601, <a href="#SD1" class="usa-link">Supplementary Figure S11A</a>) between the levels of <em>BRCA2</em>e3 skipping evaluated in the mono-allelic minigene-based assay and those assessed in RNA samples derived from patients carrying the same variants at the heterozygous state. Moreover, in order to better evaluate the contribution of WT and mutant alleles to the production of FL transcripts, we took advantage of the quantitative nature of the SNaPshot assay, which allows the measurement of allele-specific expression (ASE), <em>i.e.</em> the relative contribution of each allele to the production of RT-PCR products containing <em>BRCA2e3</em> (<a href="#F2" class="usa-link">Figure 2C</a>). ASE analysis indicated that FL transcripts expressed from the mutant alleles were in fact present in cells of a patient carrying c.102A&gt;G (53% of WT) and c.231T&gt;G (56%, 62%, 65% or 108% of WT, depending on the patient). Based on the results of our minigene assays and RT-PCR analysis of patient RNA, we concluded that the observed allelic imbalances in FL transcripts are essentially due to variant-induced <em>BRCA2</em>e3 skipping and that the variants cause partial rather than total splicing defects. Surprisingly, we did not observe an allelic imbalance for one of the carriers of c.231T&gt;G (108% of WT) despite an increase in Δ3 in patient biological material. Importantly, we found that this patient also harbors a pathogenic nonsense variation (<em>BRCA2</em> c.6515C&gt;A, p.Ser2172*) <em>in trans</em> of c.231T&gt;G. Most likely, the PTC introduced by the nonsense variation leads to nonsense-mediated decay of the transcripts expressed from this allele to a level similar to that of c.231T&gt;G-induced exon skipping. Of note, we observed a correlation between the levels of <em>BRCA2e3</em> skipping evaluated in the minigene assay and the ASE results obtained with equivalent patient-derived RNA samples (R<sup>2</sup>=0.9417, <a href="#SD1" class="usa-link">Supplementary Figure S11B</a>). We surmise from these results that the minigene assay is a good surrogate system to evaluate the spliceogenicity of <em>BRCA2e3</em> variants.</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. <em>BRCA2</em> exon 3 splicing patterns and allele-specific expression in patients carrying translationally silent variants.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb5/7484206/cb75106f8a1b/nihms-1618243-f0002.jpg" loading="lazy" height="1920" width="1684" alt="Figure 2."></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P42"><strong>(A) Alterations in the relative level of exon 3 inclusion caused by <em>BRCA2</em>e3 variants.</strong> The <em>BRCA2</em>e3 splicing patterns in patient-derived RNA samples were monitored by semi-quantitative fluorescent RT-PCR by using forward and reverse primers located in exons 2 and 5, respectively, followed by capillary electrophoresis and compared to those from healthy donors (controls). The relative levels of exon inclusion (bottom panel) refer to the amount of full-length transcripts (FL, containing exon 3) relative to the total amount of transcripts (with and without exon 3) and are representative of three independent experiments. Error bars indicate standard error of mean values (SEM). <strong>(B) Splicing pattern of <em>BRCA2</em>e3 variants shown in increasing order of spliceogenicity</strong>. The top panel shows the RT-PCR products separated on an agarose gel, whereas the bottom panel indicates the relative quantification of the same products separated by capillary electrophoresis as described in (A). Results represent the mean of three independent experiments and they all concern LCL RNA except for c.68–8_68–7delinsAA and c.102A&gt;G that refer to PAXgene samples. Error bars indicate standard error of mean values. The identities of the two RT-PCR products obtained, with (FL) or without (Δ3) exon 3, are indicated on the right. E3, exon 3. <strong>(C) Allele-specific expression of transcripts including <em>BRCA2</em> exon 3 assessed by SNaPshot analysis.</strong> Genomic segment (gDNA) and complementary DNA (cDNA) containing <em>BRCA2</em>e3 were amplified in parallel using specific primers (grey arrows) and the SNaPshot quantitative primer extension assay was then performed with a variant-specific primer (black arrow) targeting the sequence immediately upstream the <em>BRCA2</em>e3 variant. Allele-specific expression, representing the relative contribution of the variant allele to the expression of full-length <em>BRCA2</em> transcripts as compared to WT (% of WT), was measured by normalization of the cDNA peak area ratio (variant/WT) to the corresponding gDNA peak area ratio (variant/WT). Results are representative of three independent experiments. Error bars indicate standard error of mean values. P, patient.</p></figcaption></figure></section><section id="S12"><h3 class="pmc_sec_title">Functional characterization of <em>BRCA2</em>e3 spliceogenic variants in a mouse embryonic stem cell-based assay</h3>
<p id="P15">In an attempt to uncover a RNA-related threshold for <em>BRCA2</em> haploinsufficiency, we evaluated the consequences of variant-induced <em>BRCA2e3</em> skipping in <em>BRCA2</em> function by performing a mESC-based complementation assay (<a href="#F3" class="usa-link">Figure 3A</a> and <a href="#SD1" class="usa-link">Supplementary Figure S12</a>). Here, we tested seven variants: four intronic (c.68–8_68–7delinsAA, c.316+6T&gt;A, c.316+6T&gt;C, and c.316+6T&gt;G) and three synonymous (c.102A&gt;G, c.165C&gt;T and c.231T&gt;G). These variants were selected based on four main reasons. First, they caused a gradual increase in Δ3 in the minigene assay. Second, they are all translationally silent, which avoids any potential confounding effect produced by coding changes. Third, they are clinically interesting given that all except one (c.316+6T&gt;A) were identified in patients suspected of HBOC. And fourth, their pathogenicity is unknown. We also included c.68–7T&gt;A and c.316+5G&gt;C as controls because these spliceogenic variants have been unequivocally classified as neutral and pathogenic, respectively (<a href="#R12" class="usa-link" aria-describedby="R12">12</a>,<a href="#R19" class="usa-link" aria-describedby="R19">19</a>).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3. Functional analysis of <em>BRCA2</em> translationally silent variants that cause gradual increase in exon 3 skipping by using a mouse embryonic stem cell (mESC)-based assay. (A) Schematic representation of the mESC model used for the functional analysis of <em>BRCA2</em>e3 variants.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb5/7484206/7febe0602ab1/nihms-1618243-f0003.jpg" loading="lazy" height="1264" width="1920" alt="Figure 3."></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P43">PL2F7 mESCs with a conditional (<em>cko</em>) mouse <em>Brca2</em> allele (m<em>Brca2</em>) flanked with two <em>loxP</em> sites along with two halves (designated as HP and RT) of the human <em>HPRT1</em> minigene and a knockout (<em>ko</em>) of the second m<em>Brca2</em> allele were electroporated with BACs carrying human <em>BRCA2</em> (WT or variant <em>hBRCA2</em>). Resulting colonies were selected for further analysis after verification of h<em>BRCA2</em> expression by Western blot analysis (<a href="#SD1" class="usa-link">Supplementary Figure S12</a>). Then the conditional m<em>Brca2</em> allele was deleted by transient expression of Cre in the selected cells. Variants that could (fully or partially) complement BRCA2 deficiency resulted in HAT-resistant clones (<a href="#SD1" class="usa-link">Supplementary Figure S13</a>). These viable clones were used for other functional studies including sensitivity to DNA-damaging agents (<a href="#SD1" class="usa-link">Supplementary Figure S14</a>). <em>BRCA2</em>e3 splicing patterns in HAT-resistant mESC were monitored by semi-quantitative fluorescent RT-PCR, by using forward and reverse primers located in exons 2 and 5, respectively, followed by capillary electrophoresis. Results from mESC complementation assays are summarized in <a href="#T1" class="usa-link">Table 1</a>. <strong>(B) RT-PCR analysis of the splicing pattern of mESC expressing <em>hBRCA2</em> variants</strong>. The top panel shows the RT-PCR products separated on an agarose gel, whereas the bottom panel indicates the relative quantification of equivalent fluorescent RT-PCR products separated by capillary electrophoresis. Results represent the mean of three independent experiments. Error bars indicate standard error of mean values. The identities of the two RT-PCR products obtained, with (FL) or without (Δ3) exon 3, are indicated on the right. E3, exon 3; P, patient.</p></figcaption></figure><p id="P16">We first tested the ability of the variants to rescue the cell lethality conferred by loss of <em>BRCA2</em> after loxP/Cre-mediated deletion of the endogenous conditional <em>mBrca2</em> allele (<a href="#F3" class="usa-link">Figure 3A</a>, <a href="#T1" class="usa-link">Table 1</a>, <a href="#SD1" class="usa-link">Supplementary Figure S13</a>). The two loxP sites of the conditional <em>mBrca2</em> are flanked by two halves of human <em>HPRT</em> minigene, which allow selection of recombinant clones in the presence of HAT. We observed that mESCs expressing the c.316+5G&gt;C pathogenic variation were unable to form HAT-resistant colonies, indicating that <em>BRCA2</em> function was severely impaired, a result that is in agreement with the deleterious nature of this variant (<a href="#R12" class="usa-link" aria-describedby="R12">12</a>). In contrast and as expected, the neutral variation c.68–7T&gt;A (<a href="#R19" class="usa-link" aria-describedby="R19">19</a>) was able to fully complement the loss of endogenous <em>mBrca2</em>. Interestingly, the complementation phenotype of five out of the seven VUS, namely c.165C&gt;T, c.231T&gt;G, c.102A&gt;G, c.68–8_68–7delinsAA and c.316+6T&gt;C, resembled that of the neutral variant. However, in the case of c.316+6T&gt;A and c.316+6T&gt;G (variants that had the most severe splicing defects in the minigene assay among the seven VUS of interest), we observed fewer HAT-resistant colonies as compared to WT-expressing cells, indicating that <em>BRCA2</em> function was compromised in these cells resulting in incomplete/poor complementation (<a href="#SD1" class="usa-link">Supplementary Figure S13</a>).</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p id="P46">Summary of functional effects of <em>BRCA2</em>e3 variants analyzed in a mESC-based assay.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th rowspan="2" align="center" valign="middle" colspan="1">Nucleotide</th>
<th rowspan="2" align="center" valign="middle" colspan="1">Amino acid</th>
<th rowspan="2" align="center" valign="middle" colspan="1">Complementation<sup><a href="#TFN1" class="usa-link">a</a></sup>
</th>
<th rowspan="2" align="center" valign="middle" colspan="1">Sensitivity<sup><a href="#TFN2" class="usa-link">b</a></sup>
</th>
<th colspan="2" align="center" valign="middle" rowspan="1">Splicing (FL%)<sup><a href="#TFN3" class="usa-link">c</a></sup>
</th>
<th rowspan="2" align="center" valign="middle" colspan="1">Classification<sup><a href="#TFN4" class="usa-link">d</a></sup>
</th>
</tr>
<tr>
<th align="center" valign="middle" style="border-top: solid 1px" rowspan="1" colspan="1">Detected</th>
<th align="center" valign="top" style="border-top: solid 1px" rowspan="1" colspan="1">% WT</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">WT</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">90</td>
<td align="center" valign="top" rowspan="1" colspan="1">100</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
</tr>
<tr style="border-top: solid 1px">
<td align="center" valign="middle" rowspan="1" colspan="1">c.68–7T&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.?</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">nd</td>
<td align="center" valign="top" rowspan="1" colspan="1">nd</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Neutral</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.165T&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.=</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">79</td>
<td align="center" valign="top" rowspan="1" colspan="1">88</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Neutral</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.231T&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.=</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">61</td>
<td align="center" valign="top" rowspan="1" colspan="1">68</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Neutral</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.68–8_68–7delinsAA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.?</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">45</td>
<td align="center" valign="top" rowspan="1" colspan="1">50</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Neutral</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.102A&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.=</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">44</td>
<td align="center" valign="top" rowspan="1" colspan="1">49</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Neutral</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.316+6T&gt;C</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.?</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">24</td>
<td align="center" valign="top" rowspan="1" colspan="1">27</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Neutral</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.316+6T&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.?</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Poor</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS (intermediate)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.316+6T&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.?</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Poor</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11</td>
<td align="center" valign="top" rowspan="1" colspan="1">12</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS (intermediate)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.316+5G&gt;C</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.?</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="middle" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Pathogenic</td>
</tr>
<tr style="border-top: solid 1px">
<td align="center" valign="middle" rowspan="1" colspan="1">c.316G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p. Gly106Arg</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Poor</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">25</td>
<td align="center" valign="top" rowspan="1" colspan="1">28</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS (intermediate)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="TFN1">
<sup>a</sup><p class="display-inline" id="P47">Complementation phenotypes of <em>BRCA2</em>e3 variants based on viability of <em>Brca2</em><sup><em>ko/ko</em></sup> mESCs expressing either WT or mutant <em>BRCA2</em> after deletion of the conditional allele (see also <a href="#F3" class="usa-link">Figure 3</a> and <a href="#SD1" class="usa-link">Supplementary Figure S13</a>).</p>
</div>
<div class="fn" id="TFN2">
<sup>b</sup><p class="display-inline" id="P48">Sensitivity of HAT-resistant mESCs (expressing either WT or mutant <em>hBRCA2</em>) to six DNA-damaging agents (olaparib, methyl methanesulfonate, Mitomycin C, cisplatin, camptothecin, and ionizing radiation). Survival was measured by XTT assay and then compared to that of mESCs expressing wild-type <em>hBRCA2</em> (see also <a href="#SD1" class="usa-link">Supplementary Figure S14</a>). n/a, not applicable.</p>
</div>
<div class="fn" id="TFN3">
<sup>c</sup><p class="display-inline" id="P49">Relative quantification of splicing events in HAT-resistant mESCs expressing either WT or mutant <em>hBRCA2</em> was evaluated by semi-quantitative fluorescent RT-PCR followed by capillary electrophoresis. Results represent the mean of three independent experiments. Values relative to %WT were extrapolated from RT-PCR results displayed in the previous column (FL%) and assuming a similar <em>BRCA2</em> expression in the different mESCs clones. nd, not determined; n/a, not applicable.</p>
</div>
<div class="fn" id="TFN4">
<sup>d</sup><p class="display-inline" id="P50">Suggested nucleotide variant classification based on the results of the mESC complementation assay.</p>
</div>
</div></section><p id="P17">Because <em>BRCA2</em> has an important role in the repair of DSBs, loss of its function renders cells vulnerable to compounds that introduce toxic DNA lesions (<a href="#R35" class="usa-link" aria-describedby="R35">35</a>). Therefore, we next tested the sensitivity of the HAT-resistant mESC to six DNA-damaging agents (cisplatin, mitomycin C, methyl methanesulfonate, olaparib, camptothecin and γ-irradiation) by cell survival measurements (<a href="#T1" class="usa-link">Table 1</a>, <a href="#SD1" class="usa-link">Supplementary Figure S14</a>). As expected, c.68–7T&gt;A-expressing cells exhibited no difference in sensitivity to various DNA-damaging agents as compared to WT-expressing cells. Similarly, mESC carrying either c.165C&gt;T, c.231T&gt;G, c.102A&gt;G, c.68–8_68–7delinsAA or c.316+6T&gt;C did not exhibit hypersensitivity to any of the DNA-damaging agents, strongly supporting that they are fully functional and are likely to be neutral variants. In contrast, c.316+6T&gt;A and c.316+6T&gt;G are associated with a severe hypersensitivity to various DNA-damaging agents as compared to WT or to c.68–7T&gt;A-expressing cells, strongly indicating an impairment in <em>BRCA2</em> function. We surmise that a reduction in FL transcripts down to 35% (as measured for the borderline c.316+6T&gt;C variant in the minigene assay) is sufficient for <em>BRCA2</em> function, whereas a level equal to or lower than 26 % FL (as measured for c.316+6T&gt;A in the minigene assay) leads to <em>BRCA2</em> haploinsufficiency in mESCs. Moreover, a total loss-of-function was observed in mESCs when FL≤5% (as measured for c.316+5G&gt;C in the minigene assay).</p>
<p id="P18">To validate the physiological relevance of the mESC system for the evaluation of variant-induced <em>BRCA2</em>e3 splicing defects, we analyzed the splicing patterns of the different <em>BRCA2</em> variants in viable mESCs by semi-quantitative RT-PCR. The WT <em>BRCA2</em> gene expressed in this system reproduced the alternative splicing of <em>BRCA2e3</em> (Δ3=10%, <a href="#F3" class="usa-link">Figure 3B</a>) typically detected in normal human cells. Importantly, we confirmed that the five VUS that were fully functional in the mESC assay had increased levels of Δ3 representing a decrease in FL transcripts down to 27% of the WT <em>BRCA2</em> FL transcripts as extrapolated from the RT-PCR results. In contrast, c.316+6T&gt;A and c.316+6T&gt;G, which showed poor mESC-complementation, had even lower relative levels of FL transcripts (17% and 12%, respectively). These data suggests that the upper threshold for <em>BRCA2</em> haploinsufficiency in the mESCs lies between ~17% and ~27% FL and that for total loss-of-function the cut-off lies below 12% FL. The results of the mESC-derived RNA analysis were fully consistent with those obtained in the minigene assay not only in terms of whether or not a variant caused aberrant splicing but also in terms of the relative severity of the splicing defects (R<sup>2</sup>=0.9974, <a href="#SD1" class="usa-link">Supplementary Figure S15</a>). Moreover, the results obtained in mESCs agree with those obtained with patient-derived samples, which highlights the physiological pertinence of the mESC model to evaluate the consequences on splicing of <em>BRCA2</em>e3 variants. A biological classification of the selected variants based on the mESC complementation results is shown on <a href="#T1" class="usa-link">Table 1</a>.</p></section><section id="S13"><h3 class="pmc_sec_title">Association of leaky <em>BRCA2</em> exon 3 variants with cancer risk</h3>
<p id="P19">In order to gain insight into the clinical significance of leaky <em>BRCA2</em>e3 spliceogenic variants, we collected patient information for the seven VUS analyzed in the mESC assay (<a href="#SD2" class="usa-link">Supplementary Table S6</a>). Only one variant (c.231G&gt;T) could be classified as neutral according to ACMG (<a href="#R36" class="usa-link" aria-describedby="R36">36</a>) and ENIGMA (<a href="#R37" class="usa-link" aria-describedby="R37">37</a>) guidelines given its: (i) high frequency in the African population (0.66%), (ii) the description of an homozygous individual in the general population and (iii) the co-occurrence <em>in trans</em> with pathogenic <em>BRCA2</em> variants in HBOC patients without a FA phenotype. These data confirm that a decrease in FL transcripts from one <em>BRCA2</em> allele at least down to ~ 60% of WT (as determined for c.231G&gt;T in the ASE analysis) is not associated with HBOC. Multifactorial likelihood analyses based on clinical, familial and tumoral data from patients carrying four of the seven VUS (c.68–8_68–7delinsAA, c.102A&gt;G, c.316G&gt;A and c.316+6T&gt;C) were inconclusive in part because few families were accessible for analysis and no co-segregation information was available.</p></section><section id="S14"><h3 class="pmc_sec_title">Functional impact of <em>BRCA2</em> missense variants of uncertain significance</h3>
<p id="P20">Finally, we extended our minigene splicing analysis to 26 <em>BRCA2e3</em> coding variants (<a href="#F4" class="usa-link">Figure 4A</a>) including all missense changes reported in the BRCA-Share database (n=23), as well as one FA-associated missense variant (c.316G&gt;A) and two previously described spliceogenic nonsense variants (c.92G&gt;A and c.145G&gt;T) (<a href="#R27" class="usa-link" aria-describedby="R27">27</a>,<a href="#R28" class="usa-link" aria-describedby="R28">28</a>), the latter used as additional <em>BRCA2e3</em> spliceogenic controls. Of note, among the 24 missense variants, 21 were described as VUS (<a href="#SD2" class="usa-link">Supplementary Table S1</a>). The minigene assay revealed that 12 out of the 26 variations tested (46%) altered the splicing pattern of <em>BRCA2</em>e3 relative to WT (<a href="#F4" class="usa-link">Figure 4B</a> and <a href="#SD2" class="usa-link">Supplementary Table S1</a>). More precisely, 11 variants increased <em>BRCA2</em>e3 skipping, including c.92G&gt;A and c.145G&gt;T as expected, and one variant (c.100G&gt;A) caused two concomitant partial splicing defects, <em>i.e</em>. skipping of <em>BRCA2</em>e3 and a 45-nucleotide in-frame deletion at the beginning of the exon caused by the creation of a new 3’ss (<a href="#SD1" class="usa-link">Supplementary Figure S16</a>). Given their positions within the exon, we suspect that c.316G&gt;C and c.316G&gt;A induce exon skipping by directly decreasing the strength of the 5’ss (<a href="#SD1" class="usa-link">Supplementary Figure S7</a>) whereas the remaining spliceogenic missense variants likely modify exonic SREs. Importantly, we confirmed that four of the variants (c.92G&gt;A, c.145G&gt;T, c.316G&gt;A and c.316G&gt;C) are associated with a major relative increase of Δ3 in patients’ RNA as compared to healthy controls (<a href="#F4" class="usa-link">Figure 4C</a>). Moreover, ASE analysis revealed a reduction in FL transcripts expressed from the mutant alleles in these biological samples (50–24% of WT, <a href="#F4" class="usa-link">Figure 4C</a>–<a href="#F4" class="usa-link">D</a>). In contrast, the 14 remaining variants showed no effect on splicing in the minigene assay (<a href="#F4" class="usa-link">Figure 4B</a>), including c.223G&gt;C, a variant that is associated, in patient RNA, with a splicing pattern similar to that observed in control samples (<a href="#F4" class="usa-link">Figure 4C</a>) and to an absence of <em>in vivo</em> allelic imbalance (<a href="#F4" class="usa-link">Figure 4D</a>), which is consistent with the minigene results.</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figure 4. RNA splicing impact of variants of unknown significance mapping to <em>BRCA2</em> exon 3. (A) Distribution of the 26 selected coding variants within <em>BRCA2</em> exon 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb5/7484206/e7a0d939b52c/nihms-1618243-f0004.jpg" loading="lazy" height="1920" width="1626" alt="Figure 4."></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P44">The diagram shows the relative position and identity of each variant within <em>BRCA2</em>e3 or its flanking intronic regions. <strong>(B) Impact of <em>BRCA2</em> exon 3 variants on splicing observed in pCAS2-based minigene assays.</strong> Wild-type and mutant pCAS2-<em>BRCA2</em>-e3 minigene constructs were transiently expressed in HeLa cells. The splicing patterns of the RNA produced from the different minigenes were then analyzed by semi-quantitative fluorescent RT-PCR followed by capillary electrophoresis. Results represent the mean of exon 3 inclusion (FL) level of three independent transfection experiments. Error bars indicate standard error of mean values. The dashed line represents the level of FL produced by the WT minigene. Solid lines indicate FL levels that discriminate different classes of variants based on the splicing pattern of pCAS2-BRCA2e3 minigenes (c.316+6T&gt;C and c.316+5G&gt;C) and taking into account results from the mESC complementation assay shown in <a href="#F3" class="usa-link">Figure 3</a>: (I) likely neutral, (II) of unknown clinical significance and (III) pathogenic variants. <strong>(C) <em>BRCA2</em> exon 3 splicing patterns assessed in patient-derived samples.</strong> The <em>BRCA2</em>e3 splicing patterns in patient-derived RNA samples were monitored by semi-quantitative fluorescent RT-PCR by using primers located in exons 2 and 5, and compared to those from healthy donors (controls). The levels of exon inclusion (FL) refer to the amount of full-length transcripts (containing exon 3) relative to the total amount of transcripts (with and without exon 3) and are representative of three independent experiments. Error bars indicate standard error of mean values (SEM). <strong>(D) Allele-specific expression of transcripts including <em>BRCA2</em> exon 3 measured by SNaPshot analysis in patient-derived samples.</strong> Genomic segment (gDNA) and complementary DNA (cDNA) containing <em>BRCA2</em>e3 were amplified in parallel using specific primers (grey arrows) and the SNaPshot quantitative primer extension assay was then performed with a variant-specific primer (black arrow) targeting the sequence immediately upstream the <em>BRCA2</em>e3 variant (star). Allele-specific expression levels representing the relative contribution of the variant allele to the expression of full-length (FL) <em>BRCA2</em> transcripts as compared to WT (% of WT), were measured by normalization of the cDNA peak area ratio (variant/WT) to the corresponding gDNA peak area ratio (variant/WT). Results are representative of three independent experiments. Error bars indicate standard error of mean values.</p></figcaption></figure><p id="P21">Our findings reiterate the importance of the minigene assay in assessing the impact on splicing of <em>BRCA2e3</em> variants. Moreover, they pinpoint c.316G&gt;A (p.Gly106Arg) as potentially leading to <em>BRCA2</em> haploinsufficiency because although the splicing efficiency of this variant (both in the minigene assay and in patient RNA) is similar to that of the borderline c.316+6T&gt;C non-coding variant, the c.316G&gt;A transition: (i) produces a Gly&gt;Arg missense change at a highly conserved amino acid position (<a href="#SD1" class="usa-link">Supplementary Figure S17</a>) in the residual <em>BRCA2</em> FL transcripts, and (ii) has been identified in <em>trans</em> of <em>BRCA2</em> c.2806_2809del (p.(Ala938Profs*21), paternal allele) in a FA patient, which is suggestive of a disease-causing hypomorphic variant.</p>
<p id="P22">To test this hypothesis, we then determined the functional consequences of c.316G&gt;A (p.Gly106Arg) in the mESC assay. As shown in <a href="#T1" class="usa-link">Table 1</a>, c.316G&gt;A lead to a drastic reduction of the number of HAT-resistant mESC colonies and a severe hypersensitivity to various DNA-damaging agents as compared to WT and to c.68–7T&gt;A, strongly indicating an impairment of <em>BRCA2</em> function. Importantly, the complementation phenotype and degree of sensitivity to DNA-damaging agents were similar to those observed for c.316+6T&gt;G and c.316+6T&gt;A (<a href="#T1" class="usa-link">Table 1</a> and <a href="#SD1" class="usa-link">Supplementary Figures S13</a>–<a href="#SD1" class="usa-link">S14</a>) revealing that indeed c.316G&gt;A (p.Gly106Arg) causes <em>BRCA2</em> haploinsufficiency but not total loss-of-function. Our results suggest that c.316G&gt;A (Gly106Arg) is a hypomorphic allele that leads to <em>BRCA2</em> haploinsufficiency because of a negative impact both on <em>BRCA2e3</em> splicing and on FL protein function.</p></section></section><section id="S15"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p id="P23">Determining the pathogenicity of leaky <em>BRCA2</em> variants remains a major challenge in medical cancer genetics. To our knowledge, only one leaky <em>BRCA2</em> variant (c.68–7T&gt;A) has been thoroughly assessed for its implication in HBOC (<a href="#R19" class="usa-link" aria-describedby="R19">19</a>). This variant has been classified as neutral by multifactorial analysis while all remaining <em>BRCA2</em> leaky variants linger as VUS until further evidence is collected (<a href="#R11" class="usa-link" aria-describedby="R11">11</a>,<a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R32" class="usa-link" aria-describedby="R32">32</a>). By using <em>BRCA2</em>e3 as a model system and complementary functional assays, we provide the first calibration of <em>BRCA2e3</em> spliceogenicity and an estimation of <em>BRCA2</em> mRNA-based haploinsufficiency, both of which contribute to the interpretation of leaky <em>BRCA2</em> variants. In addition, our study identified a plethora of new spliceogenic <em>BRCA2e3</em> variants.</p>
<p id="P24">To date, only 17 SNVs in/near <em>BRCA2</em>e3 (10 exonic and 7 intronic) have been reported as causing aberrant splicing, all shown to increase Δ3 (<a href="#R11" class="usa-link" aria-describedby="R11">11</a>,<a href="#R12" class="usa-link" aria-describedby="R12">12</a>,<a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R27" class="usa-link" aria-describedby="R27">27</a>,<a href="#R28" class="usa-link" aria-describedby="R28">28</a>,<a href="#R32" class="usa-link" aria-describedby="R32">32</a>,<a href="#R35" class="usa-link" aria-describedby="R35">35</a>,<a href="#R38" class="usa-link" aria-describedby="R38">38</a>,<a href="#R39" class="usa-link" aria-describedby="R39">39</a>). Our minigene results confirmed 15 of those initial findings (only 2 of the known spliceogenic variants being absent from our study) and uncovered 49 new splicing mutations (37 exonic, 10 intronic and 2 at the exon-intron border) bringing the number of <em>BRCA2</em>e3 spliceogenic variants to a total of 66, most affecting potential SREs. Importantly, the vast majority of the detected splicing defects were leaky (54 out of 64 spliceogenic variants), 45 being less drastic than the splicing anomaly caused by c.316+5G&gt;C but stronger than that observed for the neutral variant c.68–7T&gt;A, which implied that they remained as of unknown significance. These observations suggest that variant-induced leaky splicing defects are prevalent in <em>BRCA2e3</em> and that additional analyses are warranted for accurate assessment of their pathogenicity. Still, among the 49 newly identified spliceogenic variants, 4 caused major loss of <em>BRCA2</em>e3 in the minigene assay similar to what was observed for c.316+5G&gt;C. These variants (c.316+1G&gt;A, c.316+1G&gt;C, c.316+3A&gt;C, and c.316+4_316+6delinsCGA) can thus be classified as pathogenic without further evidence (<a href="#R12" class="usa-link" aria-describedby="R12">12</a>). Moreover, we could also immediately classify 34 non-coding variants as neutral because they either had no impact on splicing in the minigene assay or induced a minor decrease in FL transcripts (equal or milder than c.68–7T&gt;A).</p>
<p id="P25">In order to evaluate the biological significance of leaky splicing defects caused by <em>BRCA2e3</em> VUS, we next used a mESC-based assay known to reliably predict the pathogenicity of <em>BRCA2</em> variants (<a href="#R30" class="usa-link" aria-describedby="R30">30</a>,<a href="#R31" class="usa-link" aria-describedby="R31">31</a>,<a href="#R35" class="usa-link" aria-describedby="R35">35</a>,<a href="#R40" class="usa-link" aria-describedby="R40">40</a>). We found that this assay recapitulates the normal alternative splicing of <em>BRCA2</em>e3 as well as variant-induced partial splicing defects. Indeed, although <em>BRCA2</em> Δ3 levels were somewhat variable in our complementary approaches probably due to different genomic environments, tissue-specific alternative splicing patterns and/or other experimental specificities, we demonstrated a high concordance in splicing phenotypes between the mESC assay and both minigene and patient RNA analysis. Moreover, data on mESC viability and sensitivity to DNA-damage agents were concordant with the clinical classifications of c.68–7T&gt;A and c.316+5G&gt;C. By testing selected spliceogenic <em>BRCA2e3</em> VUS in the mESC assay, we were able to redefine cut-off values, extrapolated from <em>BRCA2e3</em> splicing efficiencies, meant for improving variant interpretation (<a href="#F5" class="usa-link">Figure 5A</a>–<a href="#F5" class="usa-link">B</a>). These thresholds allowed us to classify the 100 variants in our dataset as follows: 59 as neutral, 11 as pathogenic and 30 as VUS (<a href="#SD2" class="usa-link">Supplementary Table S1</a>). Our data suggests that non-coding <em>BRCA2e3</em> variants producing at least 27% FL transcripts in the mESC assay as compared to WT (or 35% in the minigene assay) can be considered neutral as they are expected to fully complement the loss of <em>BRCA2</em> in mESCs as seen for c.316+6T&gt;C. A more conservative approach would be to take into account, as threshold for neutrality, the fraction of variant-expressed FL transcripts observed for c.231T&gt;G (a minimum of 68%, 70% or ~60% FL in mESC, minigene or patients’ RNA assays, respectively, as compared to WT) given that this is clearly a non-pathogenic variant. Indeed, our results indicate, for the first time, that <em>BRCA2</em> tumor suppressor activity tolerates a substantial reduction in FL expression from one allele independently of the synthesis of alternatively spliced functional transcripts. Interestingly, certain <em>BRCA1</em> and <em>BRCA2</em> variants responsible for drastic FL losses were recently reported as not being necessarily associated with high cancer risk or total loss-of-function (<a href="#R41" class="usa-link" aria-describedby="R41">41</a>,<a href="#R42" class="usa-link" aria-describedby="R42">42</a>). However, in these cases, alternatively spliced transcripts leading to the production of potentially or partially functional isoforms (<em>BRCA1</em> Δ9,10 or <em>BRCA2</em> Δ12, respectively) were generated suggesting a rescue mechanism underlying the preserved BRCA function.</p>
<figure class="fig xbox font-sm" id="F5"><h3 class="obj_head">Figure 5. Flowcharts describing the interest of RNA splicing assays and level of expression of <em>BRCA2</em> FL transcripts for classification of <em>BRCA2</em> VUS.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb5/7484206/cb20d3e7028c/nihms-1618243-f0005.jpg" loading="lazy" height="1920" width="1492" alt="Figure 5."></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P45">(A) Extreme decision thresholds for <em>BRCA2e3</em> variants based on data from pCAS2-BRCA2e3 minigene splicing assays and mESC complementation/survival results, notably on c.316+6T&gt;C and c.316+5G&gt;C (35% FL and 5% FL thresholds, respectively). (B) Conservative decision thresholds for <em>BRCA2e3</em> variants, as well as for variants mapping outside <em>BRCA2e3</em>, based on data from allele-specific expression (ASE) analysis (<a href="#SD2" class="usa-link">Supplementary Table S1</a>). The 60% FL threshold derives from ASE results obtained with c.231T&gt;G carriers. The 4% FL threshold was extrapolated from the c.316+5G&gt;C minigene results by taking into account an adjustment factor of 0.77, which was determined by comparing minigene data with the ASE values obtained with exonic variants (<a href="#SD2" class="usa-link">Supplementary Table S1</a>). These classification charts are not valid for variants inducing the production of transcripts containing in-frame indels that can lead to the synthesis of potentially/partially functional proteins. Nonsense*, nonsense variants outside the last exon of the gene; FL, full-length reference transcripts containing <em>BRCA2e3</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.3</a>); In-F*, in-frame RNA splicing alterations not affecting essential functional domains of the BRCA2 protein, Out-F, out-of-frame RNA splicing alterations resulting in frameshift modifications of <em>BRCA2</em> transcripts.</p></figcaption></figure><p id="P26">A window of uncertainty prevails for variants showing hypomorphic phenotypes in the mESC assay such as c.316+6T&gt;A and c.316+6T&gt;G that reduce FL transcripts to ~ 15% WT in mESC (~ 25% WT in the minigene assay). It is possible that these variants confer moderate risks of breast/ovarian cancer as shown for <em>BRCA1</em> c.5096G&gt;A/p.Arg1699Gln and <em>BRCA2</em> c.9104A&gt;C/p.Tyr3035Ser (<a href="#R43" class="usa-link" aria-describedby="R43">43</a>–<a href="#R45" class="usa-link" aria-describedby="R45">45</a>) or are associated with lower penetrance (<a href="#R45" class="usa-link" aria-describedby="R45">45</a>). Non-coding spliceogenic variants with incomplete penetrance and/or variable degrees of disease expressivity have already been described in other cancer predisposition genes such as <em>RB1</em> (<a href="#R46" class="usa-link" aria-describedby="R46">46</a>), <em>PMS2</em> (<a href="#R47" class="usa-link" aria-describedby="R47">47</a>) and <em>VHL</em> (<a href="#R48" class="usa-link" aria-describedby="R48">48</a>). Possibly such variability also exists within the spectra of <em>BRCA2</em> variants.</p>
<p id="P27">Further studies will be essential for illuminating genotype-phenotype correlations of spliceogenic <em>BRCA2</em> VUS identified as leaky in this and other studies. Given the rarity of most of these variants, informative studies will more likely stem from international collaborative efforts, such as those conducted by the ENIGMA consortium (<a href="#R49" class="usa-link" aria-describedby="R49">49</a>), allowing the collection of data on large number of patients and their families as well as to perform case-control genotyping analysis to accurately estimate cancer risks conferred by individual variants. Finally, because only minimal amounts of FL transcripts seem to be required for sufficient <em>BRCA2</em> function, our study may pave the way for the development of new cancer prevention strategies based on RNA splicing correction in patients carrying <em>BRCA2</em> splicing variants, according to the paradigm of spinal muscular atrophy (<a href="#R50" class="usa-link" aria-describedby="R50">50</a>).</p></section><section id="SM1"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="SD1"><div class="caption p"><span>3</span></div>
<div class="media p" id="d39e1612"><div class="caption">
<a href="/articles/instance/7484206/bin/NIHMS1618243-supplement-3.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS1618243-supplement-3.pdf</a><sup> (2.7MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD2"><div class="caption p"><span>4</span></div>
<div class="media p" id="d39e1616"><div class="caption">
<a href="/articles/instance/7484206/bin/NIHMS1618243-supplement-4.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS1618243-supplement-4.xlsx</a><sup> (72.4KB, xlsx) </sup>
</div></div></section></section><section id="floats-group1" class="floats-group"><section class="bt xbox font-sm" id="BX1"><h2 class="obj_head">Statement of significance.</h2>
<p id="P51">Our findings demonstrate that <em>BRCA2</em> tumor suppressor function tolerates substantial reduction in full-length transcripts, helping to determine the pathogenicity of <em>BRCA2</em> leaky splicing variants, some of which may not increase cancer risk.</p></section></section><section id="S16" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p id="P28">This work was funded by a translational research grant from the French National Cancer Institute and the Direction Générale de l’Offre des Soins (INCa/DGOS, AAP/CFB/CI), by the OpenHealth Institute, the Groupement des Entreprises Françaises dans la Lutte contre le Cancer (Gefluc), the Fédération Hospitalo-Universitaire (FHU) Normandy Centre for Genomic and Personalized Medicine (NGP), the European Union and Région Normandie as well as by the Intramural Research Program from the Center for Cancer Research of the National Cancer Institute, US National Institutes of Health. Europe gets involved in Normandie with European Regional Development Fund (ERDF). HT was funded by a CIFRE PhD fellowship (#2015/0335) from the French Association Nationale de la Recherche et de la Technologie (ANRT) in the context of a public-private partnership between INSERM and Interactive Biosoftware and by two short-term fellowship from EMBO (#3436) and Cancéropôle Nord-Ouest. JA and GC were sponsored by the French INCa. The COVAR study is supported by the French Ligue contre le cancer and INCA BCB (2013-1-BCB-01-ICH-1) and by the GENETICANCER and « Cercle de l’Olympe ». We thank Sabine Tourneur (Inserm U1245, Rouen, France) for technical assistance.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations:</h2>
<dl class="def-list">
<dt>HBOC</dt>
<dd><p id="P35">hereditary breast and ovarian cancer</p></dd>
<dt>LCL</dt>
<dd><p id="P36">lymphoblastoid cell line</p></dd>
<dt>VUS</dt>
<dd><p id="P37">variants of unknown significance</p></dd>
<dt>SNV</dt>
<dd><p id="P38">single nucleotide variant</p></dd>
<dt>SRE</dt>
<dd><p id="P39">splicing regulatory element</p></dd>
<dt>FL</dt>
<dd><p id="P40">full-length transcripts</p></dd>
</dl></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="FN1">
<p id="P29">SUPPLEMENTARY DATA</p>
<p id="P30">Supplementary data include Supplementary Materials and Methods, 17 Supplementary Figures, 6 Supplementary Tables, a Supplementary Note, and Supplementary References.</p>
</div>
<div class="fn p" id="FN2">
<p id="P31">Disclosure of Potential Conflicts of Interest</p>
<p id="P32">H. Tubeuf was employed by Interactive Biosoftware for the time period October 2015-September 2018 in the context of a public-private PhD project partnership (CIFRE fellowship #2015/0335) between INSERM and Interactive Biosoftware. Astra Zeneca contributed financially to the COVAR study. No potential conflicts of interest were disclosed by the other authors.</p>
</div>
<div class="fn p" id="FN3">
<p id="P33">Consortia</p>
<p id="P34">Members of the French GGC network and of the COVAR (COsegregation of VARiants in the <em>BRCA1/2</em> and <em>PALB2</em> genes) group are listed in the <a href="#SD1" class="usa-link">Supplementary Note</a>.</p>
</div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Cline MS, Liao RG, Parsons MT, Paten B, Alquaddoomi F, Antoniou A, et al. 
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018;14:e1007752.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1007752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6324924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30586411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet&amp;title=BRCA%20Challenge:%20BRCA%20Exchange%20as%20a%20global%20resource%20for%20variants%20in%20BRCA1%20and%20BRCA2&amp;author=MS%20Cline&amp;author=RG%20Liao&amp;author=MT%20Parsons&amp;author=B%20Paten&amp;author=F%20Alquaddoomi&amp;volume=14&amp;publication_year=2018&amp;pages=e1007752&amp;pmid=30586411&amp;doi=10.1371/journal.pgen.1007752&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. 
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017;317:2402–16.</cite> [<a href="https://doi.org/10.1001/jama.2017.7112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28632866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Risks%20of%20Breast,%20Ovarian,%20and%20Contralateral%20Breast%20Cancer%20for%20BRCA1%20and%20BRCA2%20Mutation%20Carriers&amp;author=KB%20Kuchenbaecker&amp;author=JL%20Hopper&amp;author=DR%20Barnes&amp;author=K-A%20Phillips&amp;author=TM%20Mooij&amp;volume=317&amp;publication_year=2017&amp;pages=2402-16&amp;pmid=28632866&amp;doi=10.1001/jama.2017.7112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, et al. 
Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015;121:269–75.</cite> [<a href="https://doi.org/10.1002/cncr.29041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4293332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25224030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Cancers%20associated%20with%20BRCA1%20and%20BRCA2%20mutations%20other%20than%20breast%20and%20ovarian&amp;author=J%20Mersch&amp;author=MA%20Jackson&amp;author=M%20Park&amp;author=D%20Nebgen&amp;author=SK%20Peterson&amp;volume=121&amp;publication_year=2015&amp;pages=269-75&amp;pmid=25224030&amp;doi=10.1002/cncr.29041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Niraj J, Färkkilä A, D’Andrea AD. The Fanconi Anemia Pathway in Cancer. Annu Rev Cancer Biol. 2019;3:457–78.</cite> [<a href="https://doi.org/10.1146/annurev-cancerbio-030617-050422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6417835/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30882047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Cancer%20Biol&amp;title=The%20Fanconi%20Anemia%20Pathway%20in%20Cancer&amp;author=J%20Niraj&amp;author=A%20F%C3%A4rkkil%C3%A4&amp;author=AD%20D%E2%80%99Andrea&amp;volume=3&amp;publication_year=2019&amp;pages=457-78&amp;pmid=30882047&amp;doi=10.1146/annurev-cancerbio-030617-050422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Caputo S, Benboudjema L, Sinilnikova O, Rouleau E, Béroud C, Lidereau R, et al. 
Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases. Nucleic Acids Res. 2012;40:D992–1002.</cite> [<a href="https://doi.org/10.1093/nar/gkr1160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3245050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22144684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=Description%20and%20analysis%20of%20genetic%20variants%20in%20French%20hereditary%20breast%20and%20ovarian%20cancer%20families%20recorded%20in%20the%20UMD-BRCA1/BRCA2%20databases&amp;author=S%20Caputo&amp;author=L%20Benboudjema&amp;author=O%20Sinilnikova&amp;author=E%20Rouleau&amp;author=C%20B%C3%A9roud&amp;volume=40&amp;publication_year=2012&amp;pages=D992-1002&amp;pmid=22144684&amp;doi=10.1093/nar/gkr1160&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. 
ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980–985.</cite> [<a href="https://doi.org/10.1093/nar/gkt1113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3965032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24234437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=ClinVar:%20public%20archive%20of%20relationships%20among%20sequence%20variation%20and%20human%20phenotype&amp;author=MJ%20Landrum&amp;author=JM%20Lee&amp;author=GR%20Riley&amp;author=W%20Jang&amp;author=WS%20Rubinstein&amp;volume=42&amp;publication_year=2014&amp;pages=D980-985&amp;pmid=24234437&amp;doi=10.1093/nar/gkt1113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Eccles DM, Mitchell G, Monteiro ANA, Schmutzler R, Couch FJ, Spurdle AB, et al. 
BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance. Ann Oncol. 2015;26:2057–65.</cite> [<a href="https://doi.org/10.1093/annonc/mdv278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5006185/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26153499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=BRCA1%20and%20BRCA2%20genetic%20testing-pitfalls%20and%20recommendations%20for%20managing%20variants%20of%20uncertain%20clinical%20significance&amp;author=DM%20Eccles&amp;author=G%20Mitchell&amp;author=ANA%20Monteiro&amp;author=R%20Schmutzler&amp;author=FJ%20Couch&amp;volume=26&amp;publication_year=2015&amp;pages=2057-65&amp;pmid=26153499&amp;doi=10.1093/annonc/mdv278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Lindor NM, Goldgar DE, Tavtigian SV, Plon SE, Couch FJ. BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management. Oncologist
2013;18:518–24.</cite> [<a href="https://doi.org/10.1634/theoncologist.2012-0452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3662842/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23615697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncologist&amp;title=BRCA1/2%20sequence%20variants%20of%20uncertain%20significance:%20a%20primer%20for%20providers%20to%20assist%20in%20discussions%20and%20in%20medical%20management&amp;author=NM%20Lindor&amp;author=DE%20Goldgar&amp;author=SV%20Tavtigian&amp;author=SE%20Plon&amp;author=FJ%20Couch&amp;volume=18&amp;publication_year=2013&amp;pages=518-24&amp;pmid=23615697&amp;doi=10.1634/theoncologist.2012-0452&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Starita LM, Ahituv N, Dunham MJ, Kitzman JO, Roth FP, Seelig G, et al. 
Variant Interpretation: Functional Assays to the Rescue. Am J Hum Genet. 2017;101:315–25.</cite> [<a href="https://doi.org/10.1016/j.ajhg.2017.07.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5590843/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28886340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Variant%20Interpretation:%20Functional%20Assays%20to%20the%20Rescue&amp;author=LM%20Starita&amp;author=N%20Ahituv&amp;author=MJ%20Dunham&amp;author=JO%20Kitzman&amp;author=FP%20Roth&amp;volume=101&amp;publication_year=2017&amp;pages=315-25&amp;pmid=28886340&amp;doi=10.1016/j.ajhg.2017.07.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3:285–98.</cite> [<a href="https://doi.org/10.1038/nrg775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11967553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Genet&amp;title=Listening%20to%20silence%20and%20understanding%20nonsense:%20exonic%20mutations%20that%20affect%20splicing&amp;author=L%20Cartegni&amp;author=SL%20Chew&amp;author=AR%20Krainer&amp;volume=3&amp;publication_year=2002&amp;pages=285-98&amp;pmid=11967553&amp;doi=10.1038/nrg775&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Bonnet C, Krieger S, Vezain M, Rousselin A, Tournier I, Martins A, et al. 
Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. J Med Genet. 2008;45:438–46.</cite> [<a href="https://doi.org/10.1136/jmg.2007.056895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18424508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Screening%20BRCA1%20and%20BRCA2%20unclassified%20variants%20for%20splicing%20mutations%20using%20reverse%20transcription%20PCR%20on%20patient%20RNA%20and%20an%20ex%20vivo%20assay%20based%20on%20a%20splicing%20reporter%20minigene&amp;author=C%20Bonnet&amp;author=S%20Krieger&amp;author=M%20Vezain&amp;author=A%20Rousselin&amp;author=I%20Tournier&amp;volume=45&amp;publication_year=2008&amp;pages=438-46&amp;pmid=18424508&amp;doi=10.1136/jmg.2007.056895&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Caputo SM, Léone M, Damiola F, Ehlen A, Carreira A, Gaidrat P, et al. 
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer. Oncotarget. 2018;9:17334–48.</cite> [<a href="https://doi.org/10.18632/oncotarget.24671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5915120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29707112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Full%20in-frame%20exon%203%20skipping%20of%20BRCA2%20confers%20high%20risk%20of%20breast%20and/or%20ovarian%20cancer&amp;author=SM%20Caputo&amp;author=M%20L%C3%A9one&amp;author=F%20Damiola&amp;author=A%20Ehlen&amp;author=A%20Carreira&amp;volume=9&amp;publication_year=2018&amp;pages=17334-48&amp;pmid=29707112&amp;doi=10.18632/oncotarget.24671&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Prakash R, Zhang Y, Feng W, Jasin M. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol. 2015;7:a016600.</cite> [<a href="https://doi.org/10.1101/cshperspect.a016600" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4382744/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25833843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cold%20Spring%20Harb%20Perspect%20Biol&amp;title=Homologous%20recombination%20and%20human%20health:%20the%20roles%20of%20BRCA1,%20BRCA2,%20and%20associated%20proteins&amp;author=R%20Prakash&amp;author=Y%20Zhang&amp;author=W%20Feng&amp;author=M%20Jasin&amp;volume=7&amp;publication_year=2015&amp;pages=a016600&amp;pmid=25833843&amp;doi=10.1101/cshperspect.a016600&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Martinez JS, Baldeyron C, Carreira A. Molding BRCA2 function through its interacting partners. Cell Cycle. 2015;14:3389–95.</cite> [<a href="https://doi.org/10.1080/15384101.2015.1093702" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4825613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26566862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Cycle&amp;title=Molding%20BRCA2%20function%20through%20its%20interacting%20partners&amp;author=JS%20Martinez&amp;author=C%20Baldeyron&amp;author=A%20Carreira&amp;volume=14&amp;publication_year=2015&amp;pages=3389-95&amp;pmid=26566862&amp;doi=10.1080/15384101.2015.1093702&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Muller D, Rouleau E, Schultz I, Caputo S, Lefol C, Bièche I, et al. 
An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition. BMC Med Genet. 2011;12:121.</cite> [<a href="https://doi.org/10.1186/1471-2350-12-121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3198910/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21939546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med%20Genet&amp;title=An%20entire%20exon%203%20germ-line%20rearrangement%20in%20the%20BRCA2%20gene:%20pathogenic%20relevance%20of%20exon%203%20deletion%20in%20breast%20cancer%20predisposition&amp;author=D%20Muller&amp;author=E%20Rouleau&amp;author=I%20Schultz&amp;author=S%20Caputo&amp;author=C%20Lefol&amp;volume=12&amp;publication_year=2011&amp;pages=121&amp;pmid=21939546&amp;doi=10.1186/1471-2350-12-121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Zou JP, Hirose Y, Siddique H, Rao VN, Reddy ES. Structure and expression of variant BRCA2a lacking the transactivation domain. Oncol Rep. 1999;6:437–40.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10023017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Rep&amp;title=Structure%20and%20expression%20of%20variant%20BRCA2a%20lacking%20the%20transactivation%20domain&amp;author=JP%20Zou&amp;author=Y%20Hirose&amp;author=H%20Siddique&amp;author=VN%20Rao&amp;author=ES%20Reddy&amp;volume=6&amp;publication_year=1999&amp;pages=437-40&amp;pmid=10023017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Davy G, Rousselin A, Goardon N, Castéra L, Harter V, Legros A, et al. 
Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer. Eur J Hum Genet. 2017;25:1147–54.</cite> [<a href="https://doi.org/10.1038/ejhg.2017.116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5602017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28905878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Hum%20Genet&amp;title=Detecting%20splicing%20patterns%20in%20genes%20involved%20in%20hereditary%20breast%20and%20ovarian%20cancer&amp;author=G%20Davy&amp;author=A%20Rousselin&amp;author=N%20Goardon&amp;author=L%20Cast%C3%A9ra&amp;author=V%20Harter&amp;volume=25&amp;publication_year=2017&amp;pages=1147-54&amp;pmid=28905878&amp;doi=10.1038/ejhg.2017.116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Fackenthal JD, Yoshimatsu T, Zhang B, de Garibay GR, Colombo M, De Vecchi G, et al. 
Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples. J Med Genet. 2016;53:548–58.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2015-103570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27060066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Naturally%20occurring%20BRCA2%20alternative%20mRNA%20splicing%20events%20in%20clinically%20relevant%20samples&amp;author=JD%20Fackenthal&amp;author=T%20Yoshimatsu&amp;author=B%20Zhang&amp;author=GR%20de%20Garibay&amp;author=M%20Colombo&amp;volume=53&amp;publication_year=2016&amp;pages=548-58&amp;pmid=27060066&amp;doi=10.1136/jmedgenet-2015-103570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Colombo M, Lòpez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, et al. 
The BRCA2 c.68–7T &gt; A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Hum Mutat. 2018;39:729–41.</cite> [<a href="https://doi.org/10.1002/humu.23411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5947288/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29460995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=The%20BRCA2%20c.68%E2%80%937T%20&gt;%20A%20variant%20is%20not%20pathogenic:%20A%20model%20for%20clinical%20calibration%20of%20spliceogenicity&amp;author=M%20Colombo&amp;author=I%20L%C3%B2pez-Perolio&amp;author=HD%20Meeks&amp;author=L%20Caleca&amp;author=MT%20Parsons&amp;volume=39&amp;publication_year=2018&amp;pages=729-41&amp;pmid=29460995&amp;doi=10.1002/humu.23411&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Leman R, Gaildrat P, Le Gac G, Ka C, Fichou Y, Audrezet M-P, et al. 
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort. Nucleic Acids Res. 2019;</cite> [<a href="https://doi.org/10.1093/nar/gky372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6125621/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29750258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=Novel%20diagnostic%20tool%20for%20prediction%20of%20variant%20spliceogenicity%20derived%20from%20a%20set%20of%20395%20combined%20in%20silico/in%20vitro%20studies:%20an%20international%20collaborative%20effort&amp;author=R%20Leman&amp;author=P%20Gaildrat&amp;author=G%20Le%20Gac&amp;author=C%20Ka&amp;author=Y%20Fichou&amp;publication_year=2019&amp;pmid=29750258&amp;doi=10.1093/nar/gky372&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Ke S, Shang S, Kalachikov SM, Morozova I, Yu L, Russo JJ, et al. 
Quantitative evaluation of all hexamers as exonic splicing elements. Genome Res. 2011;21:1360–74.</cite> [<a href="https://doi.org/10.1101/gr.119628.110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3149502/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21659425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res&amp;title=Quantitative%20evaluation%20of%20all%20hexamers%20as%20exonic%20splicing%20elements&amp;author=S%20Ke&amp;author=S%20Shang&amp;author=SM%20Kalachikov&amp;author=I%20Morozova&amp;author=L%20Yu&amp;volume=21&amp;publication_year=2011&amp;pages=1360-74&amp;pmid=21659425&amp;doi=10.1101/gr.119628.110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Di Giacomo D, Gaildrat P, Abuli A, Abdat J, Frébourg T, Tosi M, et al. 
Functional analysis of a large set of BRCA2 exon 7 variants highlights the predictive value of hexamer scores in detecting alterations of exonic splicing regulatory elements. Hum Mutat. 2013;34:1547–57.</cite> [<a href="https://doi.org/10.1002/humu.22428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23983145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Functional%20analysis%20of%20a%20large%20set%20of%20BRCA2%20exon%207%20variants%20highlights%20the%20predictive%20value%20of%20hexamer%20scores%20in%20detecting%20alterations%20of%20exonic%20splicing%20regulatory%20elements&amp;author=D%20Di%20Giacomo&amp;author=P%20Gaildrat&amp;author=A%20Abuli&amp;author=J%20Abdat&amp;author=T%20Fr%C3%A9bourg&amp;volume=34&amp;publication_year=2013&amp;pages=1547-57&amp;pmid=23983145&amp;doi=10.1002/humu.22428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Erkelenz S, Theiss S, Otte M, Widera M, Peter JO, Schaal H. Genomic HEXploring allows landscaping of novel potential splicing regulatory elements. Nucleic Acids Res. 2014;42:10681–97.</cite> [<a href="https://doi.org/10.1093/nar/gku736" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4176321/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25147205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=Genomic%20HEXploring%20allows%20landscaping%20of%20novel%20potential%20splicing%20regulatory%20elements&amp;author=S%20Erkelenz&amp;author=S%20Theiss&amp;author=M%20Otte&amp;author=M%20Widera&amp;author=JO%20Peter&amp;volume=42&amp;publication_year=2014&amp;pages=10681-97&amp;pmid=25147205&amp;doi=10.1093/nar/gku736&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RKC, et al. 
RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. Science. 2015;347:1254806.</cite> [<a href="https://doi.org/10.1126/science.1254806" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4362528/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25525159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=RNA%20splicing.%20The%20human%20splicing%20code%20reveals%20new%20insights%20into%20the%20genetic%20determinants%20of%20disease&amp;author=HY%20Xiong&amp;author=B%20Alipanahi&amp;author=LJ%20Lee&amp;author=H%20Bretschneider&amp;author=D%20Merico&amp;volume=347&amp;publication_year=2015&amp;pages=1254806&amp;pmid=25525159&amp;doi=10.1126/science.1254806&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Rosenberg AB, Patwardhan RP, Shendure J, Seelig G. Learning the sequence determinants of alternative splicing from millions of random sequences. Cell. 2015;163:698–711.</cite> [<a href="https://doi.org/10.1016/j.cell.2015.09.054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26496609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Learning%20the%20sequence%20determinants%20of%20alternative%20splicing%20from%20millions%20of%20random%20sequences&amp;author=AB%20Rosenberg&amp;author=RP%20Patwardhan&amp;author=J%20Shendure&amp;author=G%20Seelig&amp;volume=163&amp;publication_year=2015&amp;pages=698-711&amp;pmid=26496609&amp;doi=10.1016/j.cell.2015.09.054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Tubeuf H, Charbonnier C, Soukarieh O, Blavier A, Lefebvre A, Dauchel H, et al. 
Large-scale comparative evaluation of user-friendly tools for predicting variant-induced alterations of splicing regulatory elements.</cite> [<a href="https://doi.org/10.1002/humu.24091" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32741062/" class="usa-link">PubMed</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Sanz DJ, Acedo A, Infante M, Durán M, Pérez-Cabornero L, Esteban-Cardeñosa E, et al. 
A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. Clin Cancer Res. 2010;16:1957–67.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-09-2564" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20215541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=A%20high%20proportion%20of%20DNA%20variants%20of%20BRCA1%20and%20BRCA2%20is%20associated%20with%20aberrant%20splicing%20in%20breast/ovarian%20cancer%20patients&amp;author=DJ%20Sanz&amp;author=A%20Acedo&amp;author=M%20Infante&amp;author=M%20Dur%C3%A1n&amp;author=L%20P%C3%A9rez-Cabornero&amp;volume=16&amp;publication_year=2010&amp;pages=1957-67&amp;pmid=20215541&amp;doi=10.1158/1078-0432.CCR-09-2564&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Fraile-Bethencourt E, Valenzuela-Palomo A, Díez-Gómez B, Goina E, Acedo A, Buratti E, et al. 
Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays. J Pathol. 2019;248:409–20.</cite> [<a href="https://doi.org/10.1002/path.5268" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30883759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pathol&amp;title=Mis-splicing%20in%20breast%20cancer:%20identification%20of%20pathogenic%20BRCA2%20variants%20by%20systematic%20minigene%20assays&amp;author=E%20Fraile-Bethencourt&amp;author=A%20Valenzuela-Palomo&amp;author=B%20D%C3%ADez-G%C3%B3mez&amp;author=E%20Goina&amp;author=A%20Acedo&amp;volume=248&amp;publication_year=2019&amp;pages=409-20&amp;pmid=30883759&amp;doi=10.1002/path.5268&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Soukarieh O, Gaildrat P, Hamieh M, Drouet A, Baert-Desurmont S, Frébourg T, et al. 
Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools. PLoS Genet. 2016;12:e1005756.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1005756" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4711968/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26761715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet&amp;title=Exonic%20Splicing%20Mutations%20Are%20More%20Prevalent%20than%20Currently%20Estimated%20and%20Can%20Be%20Predicted%20by%20Using%20In%20Silico%20Tools&amp;author=O%20Soukarieh&amp;author=P%20Gaildrat&amp;author=M%20Hamieh&amp;author=A%20Drouet&amp;author=S%20Baert-Desurmont&amp;volume=12&amp;publication_year=2016&amp;pages=e1005756&amp;pmid=26761715&amp;doi=10.1371/journal.pgen.1005756&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Kuznetsov SG, Chang S, Sharan SK. Functional analysis of human BRCA2 variants using a mouse embryonic stem cell-based assay. Methods Mol Biol. 2010;653:259–80.</cite> [<a href="https://doi.org/10.1007/978-1-60761-759-4_16" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6669890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20721749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods%20Mol%20Biol&amp;title=Functional%20analysis%20of%20human%20BRCA2%20variants%20using%20a%20mouse%20embryonic%20stem%20cell-based%20assay&amp;author=SG%20Kuznetsov&amp;author=S%20Chang&amp;author=SK%20Sharan&amp;volume=653&amp;publication_year=2010&amp;pages=259-80&amp;pmid=20721749&amp;doi=10.1007/978-1-60761-759-4_16&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Kuznetsov SG, Liu P, Sharan SK. Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat Med. 2008;14:875–81.</cite> [<a href="https://doi.org/10.1038/nm.1719" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2640324/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18607349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Mouse%20embryonic%20stem%20cell-based%20functional%20assay%20to%20evaluate%20mutations%20in%20BRCA2&amp;author=SG%20Kuznetsov&amp;author=P%20Liu&amp;author=SK%20Sharan&amp;volume=14&amp;publication_year=2008&amp;pages=875-81&amp;pmid=18607349&amp;doi=10.1038/nm.1719&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Théry JC, Krieger S, Gaildrat P, Révillion F, Buisine M-P, Killian A, et al. 
Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur J Hum Genet. 2011;19:1052–8.</cite> [<a href="https://doi.org/10.1038/ejhg.2011.100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3190263/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21673748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Hum%20Genet&amp;title=Contribution%20of%20bioinformatics%20predictions%20and%20functional%20splicing%20assays%20to%20the%20interpretation%20of%20unclassified%20variants%20of%20the%20BRCA%20genes&amp;author=JC%20Th%C3%A9ry&amp;author=S%20Krieger&amp;author=P%20Gaildrat&amp;author=F%20R%C3%A9villion&amp;author=M-P%20Buisine&amp;volume=19&amp;publication_year=2011&amp;pages=1052-8&amp;pmid=21673748&amp;doi=10.1038/ejhg.2011.100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Machado PM, Brandão RD, Cavaco BM, Eugénio J, Bento S, Nave M, et al. 
Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J Clin Oncol. 2007;25:2027–34.</cite> [<a href="https://doi.org/10.1200/JCO.2006.06.9443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17513806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Screening%20for%20a%20BRCA2%20rearrangement%20in%20high-risk%20breast/ovarian%20cancer%20families:%20evidence%20for%20a%20founder%20effect%20and%20analysis%20of%20the%20associated%20phenotypes&amp;author=PM%20Machado&amp;author=RD%20Brand%C3%A3o&amp;author=BM%20Cavaco&amp;author=J%20Eug%C3%A9nio&amp;author=S%20Bento&amp;volume=25&amp;publication_year=2007&amp;pages=2027-34&amp;pmid=17513806&amp;doi=10.1200/JCO.2006.06.9443&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Montalban G, Bonache S, Moles-Fernández A, Gadea N, Tenés A, Torres-Esquius S, et al. 
Incorporation of semi-quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 and BRCA2 genes. Hum Mutat. 2019;40:2296–317.</cite> [<a href="https://doi.org/10.1002/humu.23882" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31343793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Incorporation%20of%20semi-quantitative%20analysis%20of%20splicing%20alterations%20for%20the%20clinical%20interpretation%20of%20variants%20in%20BRCA1%20and%20BRCA2%20genes&amp;author=G%20Montalban&amp;author=S%20Bonache&amp;author=A%20Moles-Fern%C3%A1ndez&amp;author=N%20Gadea&amp;author=A%20Ten%C3%A9s&amp;volume=40&amp;publication_year=2019&amp;pages=2296-317&amp;pmid=31343793&amp;doi=10.1002/humu.23882&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Mesman RLS, Calléja FMGR, Hendriks G, Morolli B, Misovic B, Devilee P, et al. 
The functional impact of variants of uncertain significance in BRCA2. Genet Med. 2019;21:293–302.</cite> [<a href="https://doi.org/10.1038/s41436-018-0052-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6752316/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29988080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=The%20functional%20impact%20of%20variants%20of%20uncertain%20significance%20in%20BRCA2&amp;author=RLS%20Mesman&amp;author=FMGR%20Call%C3%A9ja&amp;author=G%20Hendriks&amp;author=B%20Morolli&amp;author=B%20Misovic&amp;volume=21&amp;publication_year=2019&amp;pages=293-302&amp;pmid=29988080&amp;doi=10.1038/s41436-018-0052-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. 
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20a%20joint%20consensus%20recommendation%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20and%20the%20Association%20for%20Molecular%20Pathology&amp;author=S%20Richards&amp;author=N%20Aziz&amp;author=S%20Bale&amp;author=D%20Bick&amp;author=S%20Das&amp;volume=17&amp;publication_year=2015&amp;pages=405-24&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Spurdle AB, Healey S, Devereau A, Hogervorst FBL, Monteiro ANA, Nathanson KL, et al. 
ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat. 2012;33:2–7.</cite> [<a href="https://doi.org/10.1002/humu.21628" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3240687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21990146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=ENIGMA--evidence-based%20network%20for%20the%20interpretation%20of%20germline%20mutant%20alleles:%20an%20international%20initiative%20to%20evaluate%20risk%20and%20clinical%20significance%20associated%20with%20sequence%20variation%20in%20BRCA1%20and%20BRCA2%20genes&amp;author=AB%20Spurdle&amp;author=S%20Healey&amp;author=A%20Devereau&amp;author=FBL%20Hogervorst&amp;author=ANA%20Monteiro&amp;volume=33&amp;publication_year=2012&amp;pages=2-7&amp;pmid=21990146&amp;doi=10.1002/humu.21628&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Biswas K, Das R, Eggington JM, Qiao H, North SL, Stauffer S, et al. 
Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay. Hum Mol Genet. 2012;21:3993–4006.</cite> [<a href="https://doi.org/10.1093/hmg/dds222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3428152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22678057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mol%20Genet&amp;title=Functional%20evaluation%20of%20BRCA2%20variants%20mapping%20to%20the%20PALB2-binding%20and%20C-terminal%20DNA-binding%20domains%20using%20a%20mouse%20ES%20cell-based%20assay&amp;author=K%20Biswas&amp;author=R%20Das&amp;author=JM%20Eggington&amp;author=H%20Qiao&amp;author=SL%20North&amp;volume=21&amp;publication_year=2012&amp;pages=3993-4006&amp;pmid=22678057&amp;doi=10.1093/hmg/dds222&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Thomassen M, Blanco A, Montagna M, Hansen TVO, Pedersen IS, Gutiérrez-Enríquez S, et al. 
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members. Breast Cancer Res Treat. 2012;132:1009–23.</cite> [<a href="https://doi.org/10.1007/s10549-011-1674-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21769658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Characterization%20of%20BRCA1%20and%20BRCA2%20splicing%20variants:%20a%20collaborative%20report%20by%20ENIGMA%20consortium%20members&amp;author=M%20Thomassen&amp;author=A%20Blanco&amp;author=M%20Montagna&amp;author=TVO%20Hansen&amp;author=IS%20Pedersen&amp;volume=132&amp;publication_year=2012&amp;pages=1009-23&amp;pmid=21769658&amp;doi=10.1007/s10549-011-1674-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Hendriks G, Morolli B, Calléja FMGR, Plomp A, Mesman RLS, Meijers M, et al. 
An efficient pipeline for the generation and functional analysis of human BRCA2 variants of uncertain significance. Hum Mutat. 2014;35:1382–91.</cite> [<a href="https://doi.org/10.1002/humu.22678" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6706860/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25146914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=An%20efficient%20pipeline%20for%20the%20generation%20and%20functional%20analysis%20of%20human%20BRCA2%20variants%20of%20uncertain%20significance&amp;author=G%20Hendriks&amp;author=B%20Morolli&amp;author=FMGR%20Call%C3%A9ja&amp;author=A%20Plomp&amp;author=RLS%20Mesman&amp;volume=35&amp;publication_year=2014&amp;pages=1382-91&amp;pmid=25146914&amp;doi=10.1002/humu.22678&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R41">
<span class="label">41.</span><cite>de la Hoya M, Soukarieh O, López-Perolio I, Vega A, Walker LC, van Ierland Y, et al. 
Combined genetic and splicing analysis of BRCA1 c.[594–2A&gt;C; 641A&gt;G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Hum Mol Genet. 2016;25:2256–68.</cite> [<a href="https://doi.org/10.1093/hmg/ddw094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5081057/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27008870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mol%20Genet&amp;title=Combined%20genetic%20and%20splicing%20analysis%20of%20BRCA1%20c.%5B594%E2%80%932A&gt;C;%20641A&gt;G%5D%20highlights%20the%20relevance%20of%20naturally%20occurring%20in-frame%20transcripts%20for%20developing%20disease%20gene%20variant%20classification%20algorithms&amp;author=M%20de%20la%20Hoya&amp;author=O%20Soukarieh&amp;author=I%20L%C3%B3pez-Perolio&amp;author=A%20Vega&amp;author=LC%20Walker&amp;volume=25&amp;publication_year=2016&amp;pages=2256-68&amp;pmid=27008870&amp;doi=10.1093/hmg/ddw094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R42">
<span class="label">42.</span><cite>Meulemans L, Mesman R, Caputo S, Krieger S, Guillaud-Bataille Guillaud-Bataille M, Caux-Moncoutier V. Skipping nonsense to maintain function: the paradigm of BRCA2 exon 12. Cancer Res.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-19-2491" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32046981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Skipping%20nonsense%20to%20maintain%20function:%20the%20paradigm%20of%20BRCA2%20exon%2012&amp;author=L%20Meulemans&amp;author=R%20Mesman&amp;author=S%20Caputo&amp;author=S%20Krieger&amp;author=M%20Guillaud-Bataille%20Guillaud-Bataille&amp;pmid=32046981&amp;doi=10.1158/0008-5472.CAN-19-2491&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R43">
<span class="label">43.</span><cite>Moghadasi S, Meeks HD, Vreeswijk MP, Janssen LA, Borg Å, Ehrencrona H, et al. 
The BRCA1 c. 5096G&gt;A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium. J Med Genet. 2018;55:15–20.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2017-104560" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28490613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=The%20BRCA1%20c.%205096G&gt;A%20p.Arg1699Gln%20(R1699Q)%20intermediate%20risk%20variant:%20breast%20and%20ovarian%20cancer%20risk%20estimation%20and%20recommendations%20for%20clinical%20management%20from%20the%20ENIGMA%20consortium&amp;author=S%20Moghadasi&amp;author=HD%20Meeks&amp;author=MP%20Vreeswijk&amp;author=LA%20Janssen&amp;author=%C3%85%20Borg&amp;volume=55&amp;publication_year=2018&amp;pages=15-20&amp;pmid=28490613&amp;doi=10.1136/jmedgenet-2017-104560&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R44">
<span class="label">44.</span><cite>Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, et al. 
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Res. 2017;77:2789–99.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-16-2568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5508554/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28283652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=BRCA2%20Hypomorphic%20Missense%20Variants%20Confer%20Moderate%20Risks%20of%20Breast%20Cancer&amp;author=H%20Shimelis&amp;author=RLS%20Mesman&amp;author=C%20Von%20Nicolai&amp;author=A%20Ehlen&amp;author=L%20Guidugli&amp;volume=77&amp;publication_year=2017&amp;pages=2789-99&amp;pmid=28283652&amp;doi=10.1158/0008-5472.CAN-16-2568&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R45">
<span class="label">45.</span><cite>Spurdle AB, Whiley PJ, Thompson B, Feng B, Healey S, Brown MA, et al. 
BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. J Med Genet. 2012;49:525–32.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2012-101037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3810416/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22889855/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=BRCA1%20R1699Q%20variant%20displaying%20ambiguous%20functional%20abrogation%20confers%20intermediate%20breast%20and%20ovarian%20cancer%20risk&amp;author=AB%20Spurdle&amp;author=PJ%20Whiley&amp;author=B%20Thompson&amp;author=B%20Feng&amp;author=S%20Healey&amp;volume=49&amp;publication_year=2012&amp;pages=525-32&amp;pmid=22889855&amp;doi=10.1136/jmedgenet-2012-101037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R46">
<span class="label">46.</span><cite>Valverde JR, Alonso J, Palacios I, Pestaña A. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genet. 2005;6:53.</cite> [<a href="https://doi.org/10.1186/1471-2156-6-53" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1298292/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16269091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Genet&amp;title=RB1%20gene%20mutation%20up-date,%20a%20meta-analysis%20based%20on%20932%20reported%20mutations%20available%20in%20a%20searchable%20database&amp;author=JR%20Valverde&amp;author=J%20Alonso&amp;author=I%20Palacios&amp;author=A%20Pesta%C3%B1a&amp;volume=6&amp;publication_year=2005&amp;pages=53&amp;pmid=16269091&amp;doi=10.1186/1471-2156-6-53&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R47">
<span class="label">47.</span><cite>Sjursen W, Bjørnevoll I, Engebretsen LF, Fjelland K, Halvorsen T, Myrvold HE. A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts. Fam Cancer. 2009;8:179–86.</cite> [<a href="https://doi.org/10.1007/s10689-008-9225-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19039682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam%20Cancer&amp;title=A%20homozygote%20splice%20site%20PMS2%20mutation%20as%20cause%20of%20Turcot%20syndrome%20gives%20rise%20to%20two%20different%20abnormal%20transcripts&amp;author=W%20Sjursen&amp;author=I%20Bj%C3%B8rnevoll&amp;author=LF%20Engebretsen&amp;author=K%20Fjelland&amp;author=T%20Halvorsen&amp;volume=8&amp;publication_year=2009&amp;pages=179-86&amp;pmid=19039682&amp;doi=10.1007/s10689-008-9225-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R48">
<span class="label">48.</span><cite>Sexton A, Rawlings L, McKavanagh G, Simons K, Winship I. A Novel von Hippel Lindau Gene Intronic Variant and Its Reclassification from VUS to Pathogenic: the Impact on a Large Family. J Genet Couns. 2015;24:882–9.</cite> [<a href="https://doi.org/10.1007/s10897-015-9875-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26323595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Genet%20Couns&amp;title=A%20Novel%20von%20Hippel%20Lindau%20Gene%20Intronic%20Variant%20and%20Its%20Reclassification%20from%20VUS%20to%20Pathogenic:%20the%20Impact%20on%20a%20Large%20Family&amp;author=A%20Sexton&amp;author=L%20Rawlings&amp;author=G%20McKavanagh&amp;author=K%20Simons&amp;author=I%20Winship&amp;volume=24&amp;publication_year=2015&amp;pages=882-9&amp;pmid=26323595&amp;doi=10.1007/s10897-015-9875-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R49">
<span class="label">49.</span><cite>Parsons MT, Tudini E, Li H, Hahnen E, Wappenschmidt B, Feliubadaló L, et al. 
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Hum Mutat. 2019;40:1557–78.</cite> [<a href="https://doi.org/10.1002/humu.23818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6772163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31131967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Large%20scale%20multifactorial%20likelihood%20quantitative%20analysis%20of%20BRCA1%20and%20BRCA2%20variants:%20An%20ENIGMA%20resource%20to%20support%20clinical%20variant%20classification&amp;author=MT%20Parsons&amp;author=E%20Tudini&amp;author=H%20Li&amp;author=E%20Hahnen&amp;author=B%20Wappenschmidt&amp;volume=40&amp;publication_year=2019&amp;pages=1557-78&amp;pmid=31131967&amp;doi=10.1002/humu.23818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R50">
<span class="label">50.</span><cite>Ramdas S, Servais L. New treatments in spinal muscular atrophy: an overview of currently available data. Expert Opinion on Pharmacotherapy. 2020;21:307–15.</cite> [<a href="https://doi.org/10.1080/14656566.2019.1704732" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31973611/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opinion%20on%20Pharmacotherapy&amp;title=New%20treatments%20in%20spinal%20muscular%20atrophy:%20an%20overview%20of%20currently%20available%20data&amp;author=S%20Ramdas&amp;author=L%20Servais&amp;volume=21&amp;publication_year=2020&amp;pages=307-15&amp;pmid=31973611&amp;doi=10.1080/14656566.2019.1704732&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>3</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7484206/bin/NIHMS1618243-supplement-3.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS1618243-supplement-3.pdf</a><sup> (2.7MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><span>4</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7484206/bin/NIHMS1618243-supplement-4.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS1618243-supplement-4.xlsx</a><sup> (72.4KB, xlsx) </sup>
</div></div></section></section></section></section></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1158/0008-5472.CAN-20-0895"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/nihms-1618243.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/7484206/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/7484206/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7484206%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7484206/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC7484206/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC7484206/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/32641407/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC7484206/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/32641407/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC7484206/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/7484206/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="NpjLnAeGzCTJCnOZ09MHMUcarF7uDhVNpzJY9sHeQkn3Ntj0g8ahj25QyxwHG2qi">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
